%PDF-1.3
%
2 0 obj
<>
endobj
15 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
4 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
10 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
11 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
1 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
16 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
13 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
12 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
7 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
5 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
14 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
6 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
8 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
3 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
9 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
17 0 obj
<>stream
2012-11-16T06:33:34+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2013-01-12T14:16:40-08:00
Acrobat Distiller 8.1.0 (Windows)
application/pdf
untitled
uuid:1e91b098-31d0-4955-b910-2689eae1697f
uuid:b344e17d-ce51-443a-9143-3dbd17364d11
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
28 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 37 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
38 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
30 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(repl)19.8(ace)14(men)11.8(t)-228.1(ther)14.5(apy)-220.3(\(H)12.2(RT\))-222.7(use)-223.9(a)-227.1(com)13(bin)14(ed)-224.2(for)15(m)-231.5(o)0(f)-224.5(est)11(rog)17.4(en)]TJ
0 -1.2203 TD
[(pro)14.1(ges)13.3(tin)-576.4(the)15.2(ra)12.4(py,)-571.4(but)-575.3(wom)17(en)-578.7(hav)15.3(ing)-574.1(und)11.2(er)12.1(gon)14.7(e)-581.6(hyst)15.7(er-)]TJ
0 -1.2266 TD
[(ect)13(omy)-289.3(gen)11.3(era)12.5(lly)-289.7(use)-293.4(es)11.4(trog)16.9(en-o)18.8(nly)-295.9(tr)11.5(eat)12.8(men)11.8(t.)]TJ
6.7246 0 0 5.9768 243.5527 707.8676 Tm
[(3,4)19.1(,16)19.1(18)]TJ
8.9663 0 0 8.9663 272.8062 703.8423 Tm
[(Sev)13.5(era)12.5(l)]TJ
-23.5086 -1.2203 TD
[(lin)14.8(es)-361.6(of)-363.6(ev)12(ide)12.5(nce)-356.7(in)-361(you)16.7(ng)-361.9(wome)17.1(n)-363.8(sug)11.9(ges)13.3(t)-367.2(tha)15.6(t)-367.2(s)0(e)11.4(x)-368.9(ste)17.3(roi)12(ds)]TJ
T*
[(may)-431.5(pla)14.6(y)-447(a)-442.1(rol)12(e)-442.5(i)0(n)-436.9(mod)15.6(ifyi)19.7(ng)-444.1(lu)14.1(ng)-444.1(fun)13.8(ct)12.9(ion.)]TJ
6.7246 0 0 5.9768 244.1763 685.9274 Tm
[(19,2)21.7(0)]TJ
8.9663 0 0 8.9663 263.1684 681.9589 Tm
[(Ora)15.7(l)-439.8(con-)]TJ
-22.4337 -1.2266 TD
[(tra)12(cep)12.1(tiv)14.2(e)-284.4(use)16.4(rs)-286.5(hav)15.3(e)-284.4(bee)14.8(n)-287.9(fou)14.4(nd)-284.6(to)-281.4(hav)15.3(e)-284.4(sig)16(nic)16.1(ant)15.6(ly)-286.2(hi)12(ghe)11.3(r)]TJ
0 -1.2203 TD
[(tot)15.3(al)-325.5(lung)-316.2(cap)12.5(ac)13.9(iti)11.4(es)-323.7(whe)14.1(n)-332.2(com)19.4(pare)17.5(d)-331.8(w)0(i)13.8(t)0(h)-326.3(nonu)14.4(se)11.4(rs.)]TJ
6.7246 0 0 5.9768 268.8377 663.9872 Tm
[(19,)19.1(21)]TJ
8.9663 0 0 8.9663 72 649.077 Tm
[(There)-563.3(is)-561.3(limited)-567.9(knowledge)-560.4(about)-564.9(the)-566.5(relationship)-567.2(be-)]TJ
-1.1128 -1.2266 TD
[(tween)-296.1(HRT)-285.4(and)-290.4(lung)-297.2(function)-292.9(in)-291.4(postmenopausal)-294.3(women.)-292.7(It)]TJ
0 -1.2203 TD
[(is)-314.7(well)-312.1(known)-312.8(that)-313.7(estrogen)-316.4(is)-314.7(traditionally)-312.9(used)-315.4(to)-313.1(improve)]TJ
T*
[(the)-427.4(structural)-432.3(integrity)-431.8(of)-426.9(all)-430.2(tissues,)-429.4(so)-427.7(it)-427.6(can)-425.8(be)-427.9(assumed)]TJ
T*
[(that)-263.1(the)-256.7(estrogen)-265.8(has)-257.1(a)-258.7(good)-259.6(effect)-259.7(on)-259.1(lung)-259.3(tissue.)-263.7(To)-258.7(provide)]TJ
0 -1.2266 TD
[(more)-500.4(objective)-502.8(data)-502(on)-499.3(the)-503.3(relationship)-503.9(of)-502.7(ERT)-497.1(and)-499.1(lung)]TJ
0 -1.2203 TD
[(function,)-637.2(we)-633.8(designed)-631.8(a)-631.8(prospective)-637.3(crossover)-635.5(study)-636.5(to)]TJ
T*
[(measure)-404.9(lung)-404.7(function)-406.7(with)-401(spirometry)-411.1(in)-398.9(postmenopausal)]TJ
0 -1.2266 TD
[(women)-479.5(taking)-483.6(and)-480.1(not)-480.8(taking)-483.6(estrogen.)-483.7(We)-479.5(hypothesized)]TJ
0 -1.2203 TD
[(that)-547.6(ERT)-547.7(would)-543.4(be)-548.1(independently)-554(associated)-548.1(with)-546.5(better)]TJ
T*
[(pulmonary)-337.1(function)-337.1(in)-335.7(postmenopausal)-338.6(women.)]TJ
/F3 1 Tf
0 -2.447 TD
[(Material)-334.6(and)-331.9(Methods)]TJ
/F10 1 Tf
0 -1.8336 TD
(Subjects)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(Th)12.6(e)-233.8(stud)12.8(y)-232(i)0(n)12(clu)14.8(ded)-227.2(60)-226.6(pos)13.5(tme)14.7(nop)11.5(aus)16.8(al)-230.7(wom)17(en)-230.9(wit)13.3(h)-231(pelv)13.4(ic)]TJ
-1.1128 -1.2203 TD
[(orga)17.9(n)-231(pro)14.1(lap)14.6(se)-222.5(\(PO)14.1(P\),)-219.7(all)-221.6(adm)12.6(itt)14.5(ed)-224.2(to)-224.5(the)-218.7(hos)11.5(pit)13.6(al)-224.3(for)-218.9(surg)17.5(ery)14(.)]TJ
T*
[(The)-278.2(stu)15.8(dy)-279.3(was)-274.3(ca)13.9(rri)14(ed)-281.1(out)-276.5(at)-278.2(De)11.4(part)16.9(men)11.8(t)-285(o)0(f)-281.5(Gyn)18.7(ecol)13.5(ogy)-270.8(and)]TJ
0 -1.2266 TD
[(Obs)16.5(tet)11.8(rics)14.1(,)-597.3(Uni)10.7(ve)12(rsi)13.4(ty)-599.2(Hos)14.9(pit)13.6(al)-597.4(in)-594.9(Spl)15.6(it,)-594.9(Cro)15.3(ati)15.5(a,)-596.8(bet)14.2(wee)11.2(n)]TJ
0 -1.2203 TD
[(Mar)13.6(ch,)-385(20)13.6(09,)-387.6(and)-379(Nove)15.6(mbe)17.1(r,)-389.3(201)14.1(0.)-388.1(Th)12.6(e)-398.2(stu)15.8(dy)-386.8(pro)14.1(toco)13.7(l)-389.2(was)]TJ
T*
[(appr)16(ove)15.6(d)-230.6(b)0(y)-230.1(the)-225.1(Uni)10.7(ve)12(rsi)13.4(ty)-226.2(Hosp)13.5(ita)15.5(l)-231.2(Eth)12.1(ics)-225.4(Com)18.5(mitt)16.9(ee,)-224(and)-227.2(a)]TJ
0 -1.2266 TD
[(wri)13.1(tt)11.7(en)-433.2(in)12(form)17.5(ed)-432.9(con)13.5(se)11.4(nt)-433.8(to)-426.9(part)16.9(ici)12.6(pat)11.3(e)-429.9(was)-426.1(obt)11.3(ain)18.9(ed)-432.9(fr)11.5(om)]TJ
0 -1.2203 TD
[(eac)14(h)-344.8(pat)11.3(ien)18.5(t.)-338.5(Wom)13.3(en)-338.4(wit)13.3(h)-344.8(pre)17(vio)11.9(us)-337.8(pel)14.2(vic)-338.7(sur)15.6(ger)14(y)-339.5(o)0(r)-338.6(pelv)13.4(ic)]TJ
T*
[(rad)15.8(iat)15.5(ion)-604(the)15.2(rapy)19.3(,)-609.9(pel)14.2(vic)-604.2(in)12.1(am)12.6(mat)15.1(ory)-602.2(di)12.4(sea)11.9(se)11.4(,)-609.9(pel)14.2(vic)-604.2(or)]TJ
0 -1.2266 TD
[(oth)12.3(er)-228.2(mali)21.1(gna)11.7(nci)12.8(es)11.4(,)-230.5(age)-225.1(old)16(er)-228.2(than)-221.7(70)-226.6(yea)15.1(rs,)-226.2(ca)13.8(rdio)15.3(pul)12.7(mo)12.3(nar)15.4(y)]TJ
0 -1.2203 TD
[(dise)17.5(ase)11.9(,)-609.9(e)0(s)11.4(p)0(e)11.4(cial)19.4(ly)-608.6(chr)15.6(oni)15.6(c)-612.6(obst)16.3(ruc)17.6(tive)-599(pul)12.7(mo)12.3(nary)-596(dise)17.5(ase)]TJ
T*
[(\(CO)15.3(PD\))-306.7(or)-313.3(ast)11.3(hma)18.5(,)-319.1(cor)16.2(tic)15.7(oste)14.5(roi)12(d)-312.8(use,)-302.7(hyp)16.1(ert)11.6(ens)14.4(ion,)-303.5(anem)18.6(ia,)]TJ
T*
[(dia)12.9(bet)14.2(es)-412.2(mel)11.7(lit)11.4(us,)-403.9(anti)12.1(coa)17.4(gul)16(ant)-414.4(the)15.2(rapy)19.3(,)-420.2(neu)14.3(rol)12(ogi)14.6(c)-416.6(dise)17.5(ase)]TJ
0 -1.2266 TD
[(tha)15.6(t)-354.6(m)0(a)15.6(y)-352.2(be)-345.7(ass)16.8(oci)13.4(at)12.7(ed)-344.3(wit)13.3(h)-351.1(bla)17.8(dde)13.1(r)-348.5(diso)14.7(rde)15.4(rs,)-340(ant)15.6(ich)12.8(oli)15.5(ner-)]TJ
0 -1.2203 TD
[(gic)-272.8(or)-275.4(du)14.6(loxe)16.9(tin)11.6(e)-278.1(med)12.2(ica)16.6(tio)12.2(n,)-278.2(imm)20.3(obi)14.6(lit)11.4(y,)-272.9(prev)16.3(iou)11.3(s)-279.5(HRT)18.1(,)-281.1(and)]TJ
T*
[(prev)16.3(io)12.7(us)-527.5(act)13.4(ive)-522.6(tob)11.3(ac)13.9(co)-526.9(smok)19.2(ing)-523.5(wer)16.7(e)-531(exc)11.3(lud)17.4(ed)-527.7(fr)11.5(om)-525.1(the)]TJ
0 -1.2266 TD
[(stud)19.2(y.)-241.3(The)-240.2(stud)19.2(y)-251(and)-233.5(con)13.5(trol)-235.1(grou)16(p)-247.9(w)0(o)14.6(men)-241.1(wer)16.7(e)-252.8(m)0(a)15.6(tche)15.9(d)-249.6(b)0(y)]TJ
0 -1.2203 TD
[(age)15.1(,)-357(hei)18.5(ght,)-346.3(bod)15.1(y)-352.2(mas)14.3(s)-355.4(i)0(n)12.1(dex)-346.5(\(BM)16.7(I\),)-346.9(pari)20.2(ty,)-342.9(and)-347.3(dur)13.9(ati)15.5(on)-353.9(of)]TJ
T*
[(pos)13.5(tme)14.7(nop)11.5(ause)16.9(.)-521.4(Pre)17(vio)11.9(usl)12.8(y,)-513.2(all)-512.4(wo)14.6(men)-513(had)-511.7(bee)14.8(n)-521.9(i)0(n)-512.8(pos)13.5(t-)]TJ
0 -1.2266 TD
[(men)11.8(opa)15.3(use)-381.9(for)-383.3(mor)11.6(e)-391.9(tha)15.6(n)-395.4(2)-391.5(yea)15.1(rs)-387.7(and)-379(had)-385.3(und)17.5(erg)14(one)-385.4(hys-)]TJ
0 -1.2203 TD
[(ter)11.6(ect)13(om)12.3(y)-326.9(and)-322(bil)13.8(at)12.7(era)12.5(l)-326(salp)13.3(in)12.1(go-)11.3(oo)13.4(pho)11.5(rec)12.8(tom)11.8(y.)]TJ
/F10 1 Tf
0 -2.4406 TD
(Protocol)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(Patient)-413.3(evaluation)-406.7(included)-415.3(medical)-404.7(history,)-411.5(gynecologic)]TJ
-1.1128 -1.2266 TD
[(examination,)-334.8(and)-328.4(dynamic)-333.2(spirometry)-335.2(testing.)-332.6(Signs)-327.3(of)-332(POP)]TJ
0 -1.2203 TD
[(were)-615.4(recorded)-616.3(on)-619.5(pelvic)-615.3(examination)-616.4(and)-612.9(described)-615.7(ac-)]TJ
T*
[(cording)-276.3(to)-275.1(the)-282(International)-275.6(Continence)-281.7(Society)-280.7(Pelvic)-273.9(Organ)]TJ
0 -1.2266 TD
[(Prolapse)-484.7(\(POP-Q\))-484.4(Classication.)]TJ
6.7246 0 0 5.9768 192.6992 187.3133 Tm
(19,22)Tj
8.9663 0 0 8.9663 212.2015 183.2881 Tm
[(The)-480.5(study)-484.8(group)-478.5(had)]TJ
-16.7494 -1.2203 TD
[(POP-Q)-426.6(prolapse)-427.8(stage)-422.9(1)-423.1(o)0(r)-420.8(more.)-427.5(BMI)-421.2(\(kg/m)]TJ
6.7246 0 0 5.9768 248.5417 176.3149 Tm
(2)Tj
8.9663 0 0 8.9663 251.8865 172.3464 Tm
[(\))-424.1(was)-426.1(calcu-)]TJ
-21.1754 -1.2203 TD
[(lated,)-489.9(and)-486.4(spirometry)-493.3(was)-489.3(performed)-493.2(in)-487.5(all)-487.1(women.)-488.7(Eva-)]TJ
0 -1.2266 TD
[(luation)-254.8(was)-249(generally)-253.2(performed)-259.3(between)-249.9(9)-252.4(a.m.)-249.5(and)-252.5(11)-251.9(a.m.,)]TJ
0 -1.2203 TD
[(with)-350.5(the)-357.8(respiratory)-350.5(laboratory)-353.9(personnel)-357.7(being)-350.8(unaware)-353.8(of)]TJ
T*
[(the)-338.9(subjects)-337.4(status.)]TJ
/F10 1 Tf
0 -2.447 TD
[(Testing)-335.1(of)-330.4(pulmonary)-338.5(function)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(Spirometry)-382.9(was)-375.5(done)-382.1(in)-380(all)-379.6(women)-378.3(prior)-382.1(to)-376.3(surgery)-379.5(and)]TJ
-1.1128 -1.2203 TD
[(repeated)-257.7(at)-259.2(6)-252.4(months.)-258.4(The)-252.9(forced)-259(expiratory)-262.1(maneuvers)-257.3(were)]TJ
T*
[(performed)-259.3(according)-249.8(to)-256.2(the)-256.7(American)-251.9(Thoracic)-258.1(Society)-255.4(\(ATS\))]TJ
0 -1.2267 TD
[(and)-442.2(the)-440(European)-448.3(Respiratory)-442.5(Society)-445.1(\(ERS\))-442.9(recommenda-)]TJ
27.9978 74.5598 TD
(tions.)Tj
6.7246 0 0 5.9768 334.4881 729.751 Tm
(8,9,20,23)Tj
8.9663 0 0 8.9663 363.9117 725.7825 Tm
[(Spirometry)-471.5(was)-464(performed)-467.9(using)-469.3(a)-461.1(computed)]TJ
-5.6717 -1.2203 TD
[(spirometer)-457.1(\()-82.7(MASTERLAB,)-455.5(Jaeger,)-456.7(Germany\).)-450.2(Volume)-456.9(cali-)]TJ
0 -1.2266 TD
[(brations)-427.1(were)-419.4(performed)-423.7(before)-425.5(each)-425.7(test.)-422.4(The)-417.3(participants)]TJ
0 -1.2203 TD
[(were)-242.4(seated,)-241(with)-236.6(the)-237.7(nose)-241.3(clip)-241.6(in)-234.5(place.)-240.4(They)-238.3(were)-236.1(instructed)]TJ
T*
[(to)-325.7(breathe)-324.4(spontaneously,)-325.6(then,)-326.2(without)-323.4(rushing,)-324.5(the)-319.9(subject)]TJ
0 -1.2266 TD
[(would)-322.1(inhale)-316.8(her)-313.8(vital)-317.6(capacity,)-313.8(followed)-321.1(by)-312.3(complete,)-317.5(most)]TJ
0 -1.2203 TD
[(forceful)-457.4(expiration)-453.6(through)-452.8(the)-452.7(mouthpiece.)-448.7(The)-455.2(following)]TJ
T*
[(parameters)-690.1(of)-679.8(the)-686.6(owvolume)-683(curve)-684.9(were)-678.7(considered:)]TJ
0 -1.2266 TD
[(Forced)-383.1(expired)-377.3(vital)-380.8(capacity)-380.4(\(FVC\),)-378(FEV1,)-379.4(peak)-378.2(expiratory)]TJ
0 -1.2203 TD
[(ow)-412.1(\(PEF\),)-404.7(forced)-410.8(expiratory)-413.9(ow)-405.7(at)-411(75%)-405.3(of)-407.9(FVC)-405.8(\(FEF75\),)]TJ
T*
[(forced)-436.1(expiratory)-426.5(ow)-431(at)-429.9(50%)-424.3(of)-433.2(FVC)-424.7(\(FEF50\),)-432(and)-429.5(forced)]TJ
T*
[(expiratory)-300(ow)-291.9(at)-290.8(25%)-297.8(of)-287.8(FVC)-298.3(\(FEF25\).)-292.9(Real)-291.7(timegenerated)]TJ
0 -1.2266 TD
[(owvolume)-404.8(curves)-401.6(were)-406.8(checked;)-404.1(if)-396(high-frequency)-408.4(irreg-)]TJ
0 -1.2203 TD
[(ularities)-330(were)-318.3(present,)-326.1(the)-326.2(measurement)-324(was)-318.6(discarded.)-326(The)]TJ
T*
[(subjects)-411.3(repeated)-415.7(the)-408.4(test)-406.8(until)-410.6(three)-409(acceptable)-411.8(maneuvers)]TJ
0 -1.2266 TD
[(were)-330.9(collected,)-330.7(in)-329.4(which)-333.7(the)-326.2(highest)-332.6(two)-327.3(values)-335.1(of)-325.7(FVC)-329.9(and)]TJ
0 -1.2203 TD
[(FEV1)-306.9(differed)-308.1(by)-306(5%)-298.3(or)-307(less.)-306.2(Last,)-304.4(the)-307.3(data)-306(corresponding)-304.7(to)]TJ
T*
[(the)-338.9(maneuver)-338.2(with)-331.5(highest)-338.9(FEV1)-332.2(were)-337.2(taken.)]TJ
6.7246 0 0 5.9768 494.0219 543.4581 Tm
(8,9)Tj
/F10 1 Tf
8.9663 0 0 8.9663 313.0582 517.5494 Tm
[(Hormone)-340.4(replacement)-333.8(therapy)-332.7(use)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(None)-436(of)-433.2(the)-440(subjects)-436.6(had)-435.9(previously)-436.9(received)-436.9(HRT.)-433.8(The)]TJ
-1.1128 -1.2203 TD
[(participants)-412.8(were)-400.5(randomly)-406.9(divided)-402.4(into)-408.5(two)-403.2(groups)-403.9(of)-407.9(30)]TJ
T*
[(subjects:)-370(ERT)-358(group)-364.7(\()]TJ
/F6 1 Tf
9.6361 0 TD
(n)Tj
/F7 1 Tf
.7208 0 TD
(=)Tj
/F5 1 Tf
.7145 0 TD
[(30\))-366.2(administered)-363.6(orally)-362.2(1)-163.9(m)0(g)-362.4(estra-)]TJ
-11.0714 -1.2266 TD
[(diol)-506(hemihydrate)-502.6(\(1)-164.4(mg/day\))-499.3(for)-503.4(6)-499(months;)-498.7(and)-505.4(non-ERT)]TJ
0 -1.2203 TD
[(group)-339.4(\()]TJ
/F6 1 Tf
3.3259 0 TD
(n)Tj
/F7 1 Tf
.7208 0 TD
(=)Tj
/F5 1 Tf
.7145 0 TD
[(30\))-334.6(not)-335.4(taking)-331.9(ERT.)]TJ
/F10 1 Tf
-4.7612 -2.447 TD
[(Statistical)-342.4(analysis)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(In)-378.6(statistical)-386(analysis,)-379.9(descriptive)-380.5(and)-379(analytical)-383.4(methods)]TJ
-1.1128 -1.2203 TD
[(were)-394.1(used,)-394.2(based)-393.8(on)-391.9(data)-388.2(type)-391.8(and)-391.6(distribution.)-398.1(The)-392(mean)]TJ
T*
[(and)-429.5(standard)-434.5(deviations)-429.2(were)-432.1(used)-429.2(as)-424.5(measures)-431.5(of)-433.2(central)]TJ
0 -1.2266 TD
[(tendency)-285.6(and)-271.5(variability.)-279.7(Categorical)-279.4(data)-280.7(were)-274(expressed)-281.4(as)]TJ
0 -1.2203 TD
[(absolute)-500.1(and)-492.8(relative)-495.1(numbers)-489.2(\(percentage\).)-499.5(The)]TJ
/F6 1 Tf
22.7498 0 TD
(t)Tj
/F5 1 Tf
.3225 0 TD
[(-test)-495.8(for)]TJ
-23.0723 -1.2203 TD
[(independent)-400.6(samples)-396.5(\(for)-396.4(comparison)-391.6(of)-395.3(groups\))-398.1(and)]TJ
/F6 1 Tf
24.495 0 TD
(t)Tj
/F5 1 Tf
.3225 0 TD
(-test)Tj
-24.8174 -1.2203 TD
[(for)-465.5(dependent)-469.6(samples)-466.1(\(for)-466(comparison)-467.4(of)-464.8(serial)-470.1(measure-)]TJ
0 -1.2266 TD
[(ments)-489.5(in)-481.1(the)-478(same)-485.2(patients\))-484.6(were)-482.7(used.)-482.7(The)-480.5(analysis)-484.4(was)]TJ
0 -1.2203 TD
[(performed)-461.6(using)-450.3(R)-453.2(software)-455.7(\(www.r-project.org\),)-463(with)-451.6(the)]TJ
T*
[(level)-336.4(of)-338.4(signicance)-336.7(set)-330.5(at)]TJ
/F6 1 Tf
11.748 0 TD
(p)Tj
/F7 1 Tf
.6702 0 TD
(<)Tj
/F5 1 Tf
.7145 0 TD
(0.05.)Tj
/F3 1 Tf
-13.1327 -2.447 TD
(Results)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(This)-321.1(study)-320.4(included)-314.2(60)-321.5(postmenopausal)-319.6(women)-321.4(who)-317.6(had)]TJ
-1.1128 -1.2203 TD
[(undergone)-562.6(surgery)-556.6(for)-554(uterine)-559.3(prolapse.)-557.1(All)-558.6(women)-555.3(had)]TJ
0 -1.2267 TD
[(surgical)-500.5(hysterectomy)-501.5(and)-499.1(salpingo-oophorectomy)-506.4(\(castra-)]TJ
0 -1.2203 TD
[(tion\).)-304.4(Women)-299.8(were)-299.3(randomly)-299.4(divided)-301.2(into)-301(two)-295.7(groups)-302.8(of)-300.4(30)]TJ
T*
[(subjects:)-496.5(Group)-485.5(1)-492.7(\()]TJ
/F6 1 Tf
8.8521 0 TD
(n)Tj
/F7 1 Tf
.7145 0 TD
(=)Tj
/F5 1 Tf
.7208 0 TD
[(30\))-486.4(administered)-490(ERT)-490.8(with)-489.6(1)-163.9(m)0(g)-488.8(o)0(f)]TJ
-10.2874 -1.2203 TD
[(estradiol)-400.4(hemihydrate)-395.1(\(1)-164.4(mg/day\))-391.8(orally)-393.8(for)-396(6)-391.5(months,)-397.5(and)]TJ
0 -1.2266 TD
[(group)-478.5(2)-467.4(\()]TJ
/F6 1 Tf
4.4324 0 TD
(n)Tj
/F7 1 Tf
.7208 0 TD
(=)Tj
/F5 1 Tf
.7208 0 TD
[(30\))-473.7(not)-468.2(taking)-477.3(ERT.)-468.4(Comparison)-474.7(of)-477.5(the)-471.6(basic)]TJ
-5.874 -1.2203 TD
[(anthropometric)-483.7(indicators)-485.4(and)-473.8(age)-478(showed)-479.9(no)-480.4(statistically)]TJ
T*
[(signicant)-300.1(difference)-301.4(between)-294.1(the)-294.6(two)-295.7(groups.)-299.4(There)-297.7(was)-293.3(no)]TJ
0 -1.2266 TD
[(statistically)-311.8(signicant)-306.4(difference)-314(in)-304.1(the)-307.3(number)-304.5(of)-306.7(deliveries)]TJ
0 -1.2203 TD
[(and)-657.2(abortions)-657.5(in)-651.9(the)-655(patients)-663.1(histories)-655.5(or)-654.7(in)-651.9(the)-655(post-)]TJ
T*
[(menopause)-342.2(duration)-337.2(\(Table)-333.3(1\).)]TJ
1.1128 -1.2266 TD
[(Analysis)-334.6(of)-332(changes)-333.7(in)-329.4(spirometry)-335.2(indicators)-333.7(between)-332.1(the)]TJ
-1.1128 -1.2203 TD
[(ERT)-547.7(and)-543.3(non-ERT)-545.1(groups)-543(showed)-549.4(statistically)-545.7(signicant)]TJ
T*
[(differences)-410.2(in)-398.9(the)-402.1(former)-400.5(but)-398.3(not)-405(in)-398.9(the)-402.1(latter,)-399.5(with)-401(the)-402.1(ex-)]TJ
T*
[(ception)-364.8(that)-351.6(the)-357.8(FVC)-355.2(parameter)-360(was)-356.5(elevated,)-357.6(although)-360.3(not)]TJ
0 -1.2267 TD
[(signicantly,)-342.5(in)-329.4(the)-338.9(ERT)-332.7(group)-333.1(\(Table)-333.3(2\).)]TJ
/F3 1 Tf
0 -2.4406 TD
(Discussion)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(It)-369.3(is)-365.2(known)-369.7(that)-364.2(estrogen)-373.3(can)-362.6(affect)-373.2(womens)-368.9(pulmonary)]TJ
-1.1128 -1.2267 TD
(functions.)Tj
6.7246 0 0 5.9768 351.7227 61.285 Tm
[(5,)-8.8(1115,1921)]TJ
8.9663 0 0 8.9663 397.4739 57.2598 Tm
[(Studies)-596.1(investigating)-597.7(the)-598.1(relationship)]TJ
/F3 1 Tf
-37.4127 77.2217 TD
(2)Tj
47.8771 0 TD
[(STIPIC)-333.8(ET)-338.7(AL.)]TJ
ET
endstream
endobj
39 0 obj
<>stream
hlTPTn"Ynу9y4FyX͊avŅ%H\[Dg P M|FIRmU4俛%yL93|T>Bxt.Lg(IY%}_4Wgl|8KjQ,. #
˧hD,F1n+6u9kŪ/6l;DfFsؔM6Q/[cޚ/ZBK(hkm;m&Io5m`Åp\$-Up}mTqJ.9sM
ŨU>P+{o4Ud6)!'~!^diy)Z9c.?DɯqـO`3KK^`/_Jq3o%ׁLv2PJ9/MlW[^P:}Pecϣ߽L=!AÖkϥ1
`[
vMČr
-jPt}yp^NB x\/12uMR '[{&JVQĉ! eU:r?cYKu+Uҹګ: O`n/6)
2
W,NJ~w>i9[*WׁMj
i]C/lw
!z&U?kݚvEf
p8Ú48j;`6VȨw`Rh6O<'Pe&ay".F7['gP|hgGF
D
QtPb?Od/Lכ=0z۵KmO8&҅֏e 2
miAڔ$q|jrJ'gR:@/A@
p2;CV=݆-B_#NhO|1Я @~c}N^ޝ$Q%1/ߨao?S{
RF
A /?.OgN}-8N ȍmkj#5"Kmt_蜔v~Sc$Qwe5~=<iO9:?=rpKMq,'d'p
M14v~!FlJXeTQoDcmKL@-!B e@l AH-lB;h5jY|fԢ?EZ2w`SF0,Oz"gR`y {ho /6g'=''W=]Bwd:?(gXyZFvuWT՛T,8r(< p]u
o\Wz((k^jo2-̸~I۴p]m?kyO`çD#UhA)uEIx*JwbS n9V%ÂϔV`T?An6j+_ƒ}-Z(fȅ+ >a
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 44 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
45 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
42 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 567.5526 Tm
0 0 0 rg
0 Tc
0 Tw
[(between)-534.4(hormones)-524(and)-530.7(pulmonary)-526.8(function)-526.8(among)-526.1(post-)]TJ
0 -1.2203 TD
[(menopausal)-636.2(women)-631.2(are)-632.4(limited.)]TJ
6.7246 0 0 5.9768 196.4409 560.5793 Tm
(1315)Tj
8.9663 0 0 8.9663 218.8913 556.6109 Tm
[(Estrogen)-635.6(deciency)]TJ
-17.7484 -1.2267 TD
[(after)-336.2(the)-332.5(menopause)-329.5(accelerates)-338.4(adverse)-327.5(effects)-336.9(of)-332(biological)]TJ
0 -1.2203 TD
[(aging)-508.5(on)-512(the)-509.6(lung)-512.2(mechanics)-513(in)-506.4(postmenopausal)-515.6(women.)]TJ
T*
[(These)-279.4(effects)-273.7(can)-274.1(be)-276.2(studied)-271.8(in)-272.5(a)-271.4(female)-279.1(animal)-272.6(model)-272.3(with)-274.6(a)]TJ
0 -1.2266 TD
[(long)-361.9(life)-367.8(span)-359.6(after)-361.5(ovariectomy)-365.8(\(castration\))-366(and)-366.3(postopera-)]TJ
0 -1.2203 TD
[(tive)-440.9(administration)-440(of)-439.5(ERT.)-430.5(Ovariectomy)-441.9(in)-436.9(adult)-437.8(mice)-436.6(re-)]TJ
T*
[(sulted)-426.9(in)-424.2(the)-421.1(loss)-426.2(of)-420.6(alveoli,)-427.4(absence)-425(of)-420.6(estrogen)-430.2(receptors,)]TJ
0 -1.2266 TD
[(and)-404.2(diminished)-407.9(alveolus)-411(formation,)-406.1(whereas)-404.7(ERT)-408.6(in)-405.3(ovari-)]TJ
0 -1.2203 TD
[(ectomized)-341(mice)-329.1(resulted)-339(in)-335.7(alveolar)-332.7(regeneration.)]TJ
6.7246 0 0 5.9768 256.2519 472.8755 Tm
(24,25)Tj
8.9663 0 0 8.9663 69.7323 457.9652 Tm
[(In)-384.9(the)-383.1(present)-380.1(study,)-386.5(we)-380.9(investigated)-386.9(spirometry)-379.5(param-)]TJ
-1.1128 -1.2266 TD
[(eters)-293.1(in)-291.4(postmenopausal)-294.3(women)-296.1(with)-287.2(genital)-293(prolapse.)-291.6(They)]TJ
0 -1.2203 TD
[(were)-362.5(chosen)-364.1(as)-361.2(a)-359.9(representative)-365.9(group)-364.7(with)-363.1(damaged)-361(mus-)]TJ
T*
[(cular)-339.5(and)-334.7(connective)-341.4(tissue.)-333.3(Pulmonary)-337.1(respiratory)-337.8(function)]TJ
T*
[(depends)-505(on)-505.7(the)-503.3(integrity)-507.7(of)-502.8(connective)-512.2(tissue.)-504(Previously,)]TJ
0 -1.2266 TD
[(Strinic)-477.3(et)-474.6(al.)-473.9(have)-477.8(hypothesized)-478.2(that)-478.1(connective)-474.2(tissue)-475.8(ab-)]TJ
0 -1.2203 TD
[(normalities)-452.5(are)-449(general.)-450.5(According)-447.7(to)-452.2(this)-451.3(hypothesis,)-448.4(it)-452.9(is)]TJ
T*
[(likely)-373.4(that)-370.6(the)-370.5(lung)-373.1(contains)-374.1(a)-372.6(lower)-368.9(concentration)-379.3(of)-370(colla-)]TJ
0 -1.2266 TD
[(gen.)-377.3(The)-373(authors)-369.9(found)-377.7(the)-370.5(pulmonary)-375(ventilation)-375.3(function)]TJ
0 -1.2203 TD
[(to)-338.4(be)-333.1(weakened)-334.1(in)-335.7(women)-334(with)-337.8(genital)-330.9(prolapse.)]TJ
6.7246 0 0 5.9768 255.685 363.2881 Tm
(21,26)Tj
8.9663 0 0 8.9663 69.7323 348.3779 Tm
[(We)-447.8(hypothesized)-452.9(that)-446.4(ERT)-446.5(would)-448.6(be)-446.9(independently)-452.8(as-)]TJ
-1.1128 -1.2266 TD
[(sociated)-433.4(with)-432.7(better)-435.8(pulmonary)-438.2(function)-432(in)-430.6(castrated)-434.1(post-)]TJ
0 -1.2203 TD
[(menopausal)-307.4(women)-302.4(with)-306.2(POP.)-299.5(We)-302.4(investigated)-304.7(the)-307.3(effect)-304(of)]TJ
T*
[(ERT)-459.2(on)-455.1(respiratory)-458(lung)-455.3(function)-463.6(with)-451.6(spirometry)-461.6(testing.)]TJ
T*
[(There)-253.5(are)-246.7(various)-243.9(views)-247.4(in)-247.2(the)-250.3(literature)-250.3(about)-248.8(the)-250.3(restorative)]TJ
0 -1.2266 TD
[(effects)-248.4(of)-249.8(estrogen)-246.8(on)-240.1(lung)-246.6(function.)-251.5(It)-242.9(is)-245.1(known)-243.2(that)-244.1(estrogen)]TJ
0 -1.2203 TD
[(has)-295.1(receptors)-290.9(in)-291.4(the)-294.6(lung)-290.9(and)-284.1(can)-293(have)-294.4(general)-289.6(effects)-292.7(on)-290.7(the)]TJ
T*
[(lung)-335.2(respiratory)-337.8(function)-337.1(through)-339(receptors.)]TJ
6.7246 0 0 5.9768 235.6724 275.6409 Tm
[(5,)-8.8(1115,20,24,25)]TJ
8.9663 0 0 8.9663 320.8251 567.5526 Tm
[(Analysis)-429.4(of)-433.2(changes)-434.8(in)-430.6(spirometry)-436.4(indicators)-434.8(in)-430.6(the)-433.7(two)]TJ
-1.1128 -1.2203 TD
[(study)-535.4(groups)-530.4(of)-534.4(ERT)-535(administered)-534.3(and)-530.7(non-ERT)-538.7(women)]TJ
0 -1.2267 TD
[(yielded)-352.4(statistically)-349.7(signicant)-350.6(differences)-359.6(in)-348.4(the)-351.5(ERT)-351.7(group)]TJ
0 -1.2203 TD
[(but)-309.7(no)-316(changes)-314.7(in)-310.4(the)-313.6(non-ERT)-311.1(group,)-317(with)-312.5(the)-313.6(exception)-316.2(of)]TJ
T*
[(the)-313.6(nonsignicantly)-317.5(increased)-314(FVC)-310.9(parameter)-315.8(in)-316.7(the)-313.6(former.)]TJ
1.1128 -1.2266 TD
[(Previously,)-345(two)-340(small)-340.6(studies)-346(examined)-344.1(pulmonary)-343.4(func-)]TJ
-1.1128 -1.2203 TD
[(tion)-661.4(in)-664.5(postmenopausal)-673.7(women)-662.8(who)-665.4(were)-666(on)-663.7(estrogen)]TJ
T*
[(therapy,)-335.1(one)-341.2(in)-335.7(a)-334.6(group)-333.1(of)-338.4(women)-334(without)-342.4(asthma)-336.9(and)-334.7(one)]TJ
0 -1.2266 TD
[(in)-436.9(a)-435.8(group)-434.2(of)-439.5(women)-441.5(with)-432.7(asthma.)]TJ
6.7246 0 0 5.9768 456.4345 483.8739 Tm
[(11,22,2)-9.8(7)]TJ
8.9663 0 0 8.9663 483.9305 479.8487 Tm
[(Women)-438.9(without)]TJ
-19.3038 -1.2203 TD
[(asthma)-267.3(did)-268.8(not)-265.9(have)-269.1(signicantly)-270.1(different)-271.1(FEV1)-269(values)-265.6(after)]TJ
T*
[(the)-370.5(initiation)-371.9(of)-370(ERT.)-373.6(However,)-368.9(estrogen)-373.3(therapy)-376.5(was)-369.2(asso-)]TJ
0 -1.2266 TD
[(ciated)-644.3(with)-641.3(an)-647.8(inhibitory)-643.5(effect)-645.4(on)-644.8(airway)-641.6(reactivity)-651.2(of)]TJ
0 -1.2203 TD
[(bronchial)-589.6(smooth)-583.7(muscle.)]TJ
6.7246 0 0 5.9768 417.4298 439.9936 Tm
(11)Tj
8.9663 0 0 8.9663 429.392 436.0251 Tm
[(Women)-590.7(with)-584.4(asthma)-589.8(experi-)]TJ
-13.2212 -1.2203 TD
[(enced)-511.3(a)-511.7(signicantly)-516.7(decreased)-512.3(peak)-511(expiratory)-515(ow)-513.2(and)]TJ
T*
[(increased)-554.3(bronchodilator)-561.4(requirements)-556.9(after)-557.5(estrogen)-556.6(use,)]TJ
0 -1.2266 TD
[(but)-486.8(there)-491.2(was)-489.3(no)-486.7(signicant)-496.1(difference)-491.1(in)-487.5(spirometry)-493.3(val-)]TJ
0 -1.2203 TD
(ues.)Tj
6.7246 0 0 5.9768 326.3243 396.17 Tm
(22,27)Tj
8.9663 0 0 8.9663 344.8629 392.2015 Tm
[(Both)-370(of)-376.3(these)-378(studies)-377.6(were)-368.9(small)-378.5(\()]TJ
/F6 1 Tf
15.3267 0 TD
(n)Tj
/F7 1 Tf
.7145 0 TD
(=)Tj
/F5 1 Tf
.7208 0 TD
[(15)-372.1(and)]TJ
/F6 1 Tf
3.4207 0 TD
(n)Tj
/F7 1 Tf
.7208 0 TD
(=)Tj
/F5 1 Tf
.7208 0 TD
(36,)Tj
-25.4181 -1.2203 TD
[(respectively\),)-334.6(did)-338.3(not)-335.4(control)-335.4(for)-332.7(potential)-337.4(confounders,)-337.4(and)]TJ
0 -1.2266 TD
[(considered)-560.6(only)-557.9(unopposed)-561(estrogen)-563(therapy.)-562.8(Pata)-557.3(et)-556.8(al.)]TJ
0 -1.2203 TD
[(examined)-413.6(the)-414.7(effects)-412.8(of)-414.2(three)-415.3(different)-416.5(treatment)-413.4(protocols,)]TJ
/F6 1 Tf
T*
(i.e)Tj
/F5 1 Tf
.9042 0 TD
[(.,)-423.1(estrogen,)-426.8(estrogen)-423.8(with)-426.3(progestin,)-425.4(and)-423.2(tibolone,)-428.4(on)-423.5(re-)]TJ
-.9042 -1.2266 TD
[(spiratory)-476.3(function)-482.6(in)-481.1(three)-478.6(separate)-483.2(small)-479.7(groups)-479.8(of)-477.5(post-)]TJ
0 -1.2203 TD
[(menopausal)-402.2(women.)-400.2(A)-399.7(signicant)-401.2(difference)-402.6(was)-400.8(observed)]TJ
T*
[(in)-411.6(FVC)-405.7(and)-410.6(FEV1)-414.4(only)-406.1(in)-411.6(the)-414.7(group)-408.9(of)-414.2(estrogen)-411.2(with)-413.7(pro-)]TJ
T*
[(gestin)-474.6(after)-468.9(3)-473.7(months.)-473.4(There)-474.8(was)-470.3(no)-467.7(signicant)-477.1(difference)]TJ
0 -1.2266 TD
[(between)-344.7(pre-)-337.5(and)-341(posttherapy)-344.4(values)-347.8(in)-335.7(other)-342.3(parameters.)]TJ
6.7246 0 0 5.9768 543.1747 297.5243 Tm
(14)Tj
8.9663 0 0 8.9663 310.8472 282.6141 Tm
[(A)-500.9(similar)-496.6(study)-503.7(was)-502(performed)-499.6(by)-502(Cevrioglu)-504(et)-499.9(al.,)-495.7(who)]TJ
0 -1.2203 TD
[(investigated)-829.5(the)-832.1(effects)-830.1(of)-831.5(HRT)-829.2(on)-828.1(lung)-828.4(function)-830.3(in)]TJ
ET
59.754 720.113 490.167 .22681 re
f
59.754 622.545 490.167 .28345 re
f
59.754 691.143 490.167 .28351 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 64.233 725.7825 Tm
(Table)Tj
/F5 1 Tf
3.0603 0 TD
(1.)Tj
/F9 1 Tf
1.2519 0 TD
[(Comparison)-335.9(of)-330(Age)-335.8(and)-331.7(Basic)-335.9(Anthropometric)-336.4(Indicators)-339.2(Between)]TJ
/F5 1 Tf
33.2522 0 TD
(ERT)Tj
/F9 1 Tf
2.2067 0 TD
[(Users)-333.3(and)-338(Non)]TJ
/F5 1 Tf
7.4041 0 TD
(-ERT)Tj
/F9 1 Tf
2.5292 0 TD
(Subjects)Tj
/F6 1 Tf
-22.3768 -2.0423 TD
[(ERT)-332.7(users)-6842.3(Non-ERT)-338.3(users)]TJ
-27.8271 -1.1128 TD
[(Indicator)-24796.8(\()]TJ
/F5 1 Tf
28.7503 0 TD
(n)Tj
/F7 1 Tf
.7398 0 TD
(=)Tj
/F6 1 Tf
.7145 0 TD
[(30\))-9079.2(\()]TJ
/F5 1 Tf
10.7237 0 TD
(n)Tj
/F7 1 Tf
.7398 0 TD
(=)Tj
/F6 1 Tf
.7208 0 TD
(30\))Tj
/F5 1 Tf
10.2811 0 TD
(p)Tj
/F6 1 Tf
.5944 0 TD
(*)Tj
/F5 1 Tf
-53.2642 -2.0929 TD
[(Age)-334.5(\(years\);)-338.5(mean)]TJ
/F7 1 Tf
8.264 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(SD)-17514.3(57.54)]TJ
/F7 1 Tf
21.226 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(4.27)-7298.1(57.61)]TJ
/F7 1 Tf
11.4634 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(4.98)-6798.6(0.775)]TJ
-43.1033 -1.1128 TD
[(Height)-340.5(\(cm\);)-335.8(mean)]TJ
/F7 1 Tf
8.479 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(SD)-16793.5(165.75)]TJ
/F7 1 Tf
21.0047 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(7.21)-6798.6(165.67)]TJ
/F7 1 Tf
11.4634 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(6.50)-6798.6(0.871)]TJ
-43.1033 -1.1128 TD
[(Body)-335.7(weight)-335.8(\(kg\);)-335.2(mean)]TJ
/F7 1 Tf
10.9197 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(SD)-14858.7(73.15)]TJ
/F7 1 Tf
18.5704 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(9.71)-7298.1(73.57)]TJ
/F7 1 Tf
11.4634 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(8.45)-6798.6(0.525)]TJ
-43.1033 -1.1128 TD
[(Body)-335.7(mass)-334.8(index)-334.4(\(kg/m)]TJ
6.7246 0 0 5.9768 157.096 652.8187 Tm
(2)Tj
8.9663 0 0 8.9663 160.4409 648.7935 Tm
[(\);)-332.2(mean)]TJ
/F7 1 Tf
3.4902 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(SD)-11052.3(26.74)]TJ
/F7 1 Tf
14.764 0 TD
()Tj
/F5 1 Tf
.7145 0 TD
[(3.32)-7298.1(26.19)]TJ
/F7 1 Tf
11.4634 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(3.57)-6798.6(0.458)]TJ
-43.1033 -1.1065 TD
[(Number)-339(of)-332(deliveries;)-341.4(median)-329.4(\(IQR\))-12529.7(2.0)-337.1(\(1.0\))-8703.2(2.0)-330.7(\(1.0\))-7375.4(0.161**)]TJ
0 -1.1128 TD
[(Postmenopause)-341.8(duration)-337.2(\(years\);)-338.5(median)-335.7(\(IQR\))-7629.4(4.2)-337.1(\(6.0\))-8703.2(4.7)-330.7(\(6.0\))-7375.4(0.492**)]TJ
7.9702 0 0 7.9702 67.748 610.7526 Tm
(The)Tj
/F6 1 Tf
1.9775 0 TD
(t)Tj
/F5 1 Tf
.3201 0 TD
[(-test)-333.7(was)-328(used)-330.4(for)-331.1(independe)13.6(nt)-336.6(samples,)-326.6(except)-324.7(for)-331.1(cases)-330.9(where)-332.7(the)-330.9(MannW)12.3(hitney)-334.3(test)-328.5(was)-328(used)-330.4(\(**\).)]TJ
-2.2975 -1.1239 TD
[(ERT,)-330(Estrogen)-322.5(replacemen)10.9(t)-339.5(therapy;)-327.2(SD,)-330.8(standa)11.8(rd)-334(deviation;)-327.9(IQR,)-324.5(interquarti)9(le)-332.2(range.)]TJ
ET
59.754 231.817 490.167 .22676 re
f
59.754 96.378 490.167 .22675 re
f
134.362 212.542 196.668 .22676 re
f
361.19 212.542 188.731 .22676 re
f
59.754 194.853 490.167 .22681 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 186.0661 237.4866 Tm
(Table)Tj
/F5 1 Tf
3.0603 0 TD
(2.)Tj
/F9 1 Tf
1.2519 0 TD
[(Spirometry)-332.3(Indicators)-339.2(According)-335.5(to)]TJ
/F5 1 Tf
18.2479 0 TD
(ERT)Tj
/F9 1 Tf
2.2067 0 TD
(Use)Tj
/F6 1 Tf
-20.5052 -2.0423 TD
[(ERT)-21944.4(Non-ERT)]TJ
-.6133 -2.0044 TD
(\()Tj
/F5 1 Tf
.3225 0 TD
(n)Tj
/F7 1 Tf
.7398 0 TD
(=)Tj
/F6 1 Tf
.7208 0 TD
[(30\))-21750.3(\()]TJ
/F5 1 Tf
23.3948 0 TD
(n)Tj
/F7 1 Tf
.7398 0 TD
(=)Tj
/F6 1 Tf
.7208 0 TD
(30\))Tj
-35.617 -2.0992 TD
(Mean)Tj
/F7 1 Tf
2.4786 0 TD
()Tj
/F6 1 Tf
.7208 0 TD
[(SD,)-331.2(1)-3799.6(Mean)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F6 1 Tf
.7208 0 TD
[(SD,)-331.2(2)]TJ
/F5 1 Tf
6.8414 0 TD
(p)Tj
/F6 1 Tf
.5944 0 TD
[(*)-4875.7(Mean)]TJ
/F7 1 Tf
7.7392 0 TD
()Tj
/F6 1 Tf
.7208 0 TD
[(SD,)-331.2(1)-3799.6(Mean)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F6 1 Tf
.7208 0 TD
[(SD,)-331.2(2)]TJ
/F5 1 Tf
6.3988 0 TD
(p)Tj
/F6 1 Tf
.5943 0 TD
(*)Tj
/F5 1 Tf
-53.6499 -1.1065 TD
[(FVC)-6343(103.45)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(18.2)-4016.5(107.62)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(17.8)-4901.7(0.135)-3358.4(102.64)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(14.65)-3516.5(102.38)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(14.84)-3510.2(0.527)]TJ
-46.6568 -1.1128 TD
[(FEV1)-6446.5(91.18)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(16.97)-4016(98.89)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(17.32)-4401.7(0.017)-3857.9(87.56)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(12.09)-4016(86.19)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(12.52)-3510.2(0.035)]TJ
-46.6568 -1.1128 TD
[(PEF)-7071.5(75.72)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(28.86)-4016(92.82)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
(28.93)Tj
/F7 1 Tf
5.9309 0 TD
(<)Tj
/F5 1 Tf
.7208 0 TD
[(0.001)-3857.9(72.59)]TJ
/F7 1 Tf
8.5233 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(20.93)-4016(73.96)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(20.86)-3510.2(0.205)]TJ
-46.6568 -1.1128 TD
[(FEV1/FVC)-3864.5(97.23)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(12.75)-3516.5(102.46)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(10.4)-4901.7(0.005)-3857.9(93.91)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(11.18)-4016(93.66)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(12.7)-4010.2(0.717)]TJ
-46.6568 -1.1065 TD
[(FEF2575)-4612.5(64.55)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(20.97)-4016(81.08)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(25.62)-4401.7(0.001)-3857.9(61.17)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(19.71)-4016(60.76)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(21.41)-3510.2(0.768)]TJ
-46.6568 -1.1128 TD
[(MEF75%)-4894.5(75.21)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(27.26)-4016(92.25)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
(26.48)Tj
/F7 1 Tf
5.9309 0 TD
(<)Tj
/F5 1 Tf
.7208 0 TD
[(0.001)-3857.9(69.08)]TJ
/F7 1 Tf
8.5233 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(22.04)-4016(68.95)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(22.93)-3510.2(0.922)]TJ
-46.6568 -1.1128 TD
[(MEF50%)-4894.5(66.31)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(20.8)-4516(80.33)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(23.63)-4401.7(0.003)-3857.9(61.09)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(17.58)-4016(59.82)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(18.82)-3510.2(0.350)]TJ
-46.6568 -1.1128 TD
[(MEF25%)-4894.5(62.82)]TJ
/F7 1 Tf
11.2358 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(27.58)-4016(81.29)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(36.21)-4401.7(0.001)-3857.9(58.21)]TJ
/F7 1 Tf
15.175 0 TD
()Tj
/F5 1 Tf
.7208 0 TD
[(26.45)-4016(58.54)]TJ
/F7 1 Tf
8.6814 0 TD
()Tj
/F5 1 Tf
8.9663 0 0 8.9663 478.0912 102.6708 Tm
[(27.36)-3510.2(0.880)]TJ
7.9702 0 0 7.9702 67.748 84.5858 Tm
(*)Tj
/F6 1 Tf
.3841 0 TD
(t)Tj
/F5 1 Tf
.3201 0 TD
[(-test)-333.7(for)-331.1(independen)9.4(t)-332.4(samples.)]TJ
-.7042 -1.1239 TD
[(ERT,)-308.7(Estrogen)-301.2(replacement)-307.3(therapy;)-305.8(SD,)-309.4(standard)-300.9(deviation;)-306.6(FVC,)-311.4(forced)-301.7(vital)-308.9(capacity;)-310.5(FEV1,)-306.6(forced)-301.7(expired)-311.6(volume)-300.6(in)-313.6(1)-310.9(sec;)-314(PEF,)-305.7(peak)]TJ
-1.003 -1.131 TD
[(expiratory)-435.1(ow;)-432.3(FEF2575,)-428.7(forced)-436.8(expiratory)-435.1(ow)-433.4(at)-437(25%75%)-429.1(of)-438.7(FVC;)-432.3(MEF25%,)-433.3(ow)-433.4(at)-437(25%)-436.1(of)-438.7(FVC;)-439.4(MEF50%)13.8(,)-440(ow)-440.5(at)-437(50%)-436.1(of)-438.7(FVC;)]TJ
0 -1.1239 TD
[(MEF75%,)-326.6(ow)-326.7(at)-330.3(75%)-329.4(of)-332(FVC.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(ESTROGEN)-339.9(IMPROVES)-337.8(LUNG)-330.5(FUNCTION)]TJ
54.1178 0 TD
(3)Tj
ET
endstream
endobj
46 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 48 0 R/MediaBox[0 0 612 792]/Annots[49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R]/Rotate 0>>
endobj
58 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
47 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(postmenopausal)-484(women.)-476.1(The)-480.5(authors)-477.4(divided)-478.3(the)-478(respon-)]TJ
0 -1.2203 TD
[(dents)-412.7(into)-408.5(three)-409(small)-410.1(groups.)-406.9(A)-406.1(statistically)-412.9(signicant)-407.5(in-)]TJ
0 -1.2266 TD
[(crease)-348.4(was)-350.2(observed)-354.2(only)-349.2(in)-348.4(the)-345.2(FVC)-348.8(and)-353.7(FEV1)-344.9(parameters)]TJ
0 -1.2203 TD
[(of)-249.8(the)-244(estrogen)]TJ
/F7 1 Tf
6.6138 0 TD
(+)Tj
/F5 1 Tf
.7208 0 TD
[(progestin)-251.8(group)-244.5(after)-247.6(3)-246.1(months)-249.2(of)-243.5(therapy.)]TJ
6.7246 0 0 5.9768 294.4062 696.8691 Tm
(15)Tj
8.9663 0 0 8.9663 62.022 681.9589 Tm
[(The)-392(only)-393.5(relevant)-393.8(study)-389.9(that)-395.9(is)-390.5(comparable)-387.9(to)-395.3(our)-390.5(study)-389.9(is)]TJ
0 -1.2266 TD
[(the)-395.8(one)-398.1(by)-394.5(Carlson)-397.1(et)-398.7(al.)]TJ
6.7246 0 0 5.9768 162.9354 674.9856 Tm
(13)Tj
8.9663 0 0 8.9663 173.1968 670.9604 Tm
[(These)-399.5(authors)-401.5(examined)-394.6(the)-395.8(re-)]TJ
-12.3992 -1.2203 TD
[(lationship)-484.4(of)-483.8(HRT)-481.4(with)-476.9(spirometry)-486.9(in)-481.1(2,353)-475.2(women)-485.8(older)]TJ
T*
[(than)-278.6(65)-270.9(years)-277.7(and)-271.5(participating)-280.3(in)-278.8(the)-275.6(Cardiovascular)-274.9(Health)]TJ
0 -1.2266 TD
[(Study)-463(in)-468.5(1993/1994.)-457.3(Current)-468.3(HRT)-462.5(use)-464.1(was)-464(dened)-461.1(as)-468.7(es-)]TJ
0 -1.2203 TD
[(trogen)-277.2(or)-275.4(estrogen/progestin)-280.3(use.)-271(Of)-275.4(the)-275.6(women)-277.1(using)-273.2(HRT,)]TJ
T*
[(81.4%)-357.2(were)-362.5(using)-355.4(unopposed)-365(estrogen,)-363.5(and)-353.7(18.6%)-357.2(were)-362.5(us-)]TJ
T*
[(ing)-485.6(combined)-494.4(estrogen/progestin.)-491.9(The)-493.2(study)-484.8(showed)-492.5(that)]TJ
0 -1.2266 TD
(estrogen)Tj
/F7 1 Tf
3.8949 0 TD
(+)Tj
/F5 1 Tf
.7208 0 TD
[(progestin)-586.9(users)-586.3(had)-587.6(the)-585.5(highest)-585.5(levels)-590.6(of)-585(FVC)]TJ
-4.6157 -1.2203 TD
[(and)-246.2(FEV1,)-240.3(which)-245.2(the)-250.3(authors)-243.5(could)-250.2(not)-240.6(explain.)]TJ
6.7246 0 0 5.9768 248.0881 587.2817 Tm
(13)Tj
8.9663 0 0 8.9663 257.0456 583.3132 Tm
[(Among)-243.5(the)]TJ
-21.7508 -1.2203 TD
[(respondents)-491.7(were)-489(women)-485.8(with)-489.6(asthma)-488.6(and)-486.4(smokers,)-485.1(and)]TJ
0 -1.2266 TD
[(they)-438.1(were)-432.1(on)-436.1(average)-434.6(signicantly)-434.5(older)-433.5(than)-436.7(our)-434.8(subjects)]TJ
0 -1.2203 TD
[(were.)-245.3(Furthermore,)-248.7(individual)-252.8(doses)-242.2(and)-246.2(duration)-248.7(of)-249.8(therapy)]TJ
T*
[(were)-337.2(unknown.)]TJ
6.7246 0 0 5.9768 124.611 543.4581 Tm
(13)Tj
8.9663 0 0 8.9663 72 528.4912 Tm
[(On)-385.8(the)-389.5(other)-386.6(hand,)-391.6(in)-386.3(women)-384.6(aged)-386.2(2435,)-386.2(the)-389.5(use)-388.3(of)-388.9(an)]TJ
-1.1128 -1.2203 TD
[(oral)-607.2(contraceptive)-612(containing)-611.7(estradiol)-609.1(and)-612.9(progestin)-605.9(in-)]TJ
T*
[(creased)-345(the)-345.2(FEF)-347(rates,)-346.2(especially)-345.1(ow)-342.5(rates)-343.3(at)-347.7(low)-343(lung)-341.5(vol-)]TJ
T*
(umes.)Tj
6.7246 0 0 5.9768 85.3795 499.6345 Tm
(21)Tj
8.9663 0 0 8.9663 95.0173 495.666 Tm
[(Hence,)-334.2(these)-327.4(ndings)-331.9(in)-329.4(young)-326.2(women)-327.7(point)-327.7(to)-332(the)]TJ
-3.6799 -1.2266 TD
-.0189 Tc
[(alveolar-)5.9(m)-3.8(aintaining)-364.8(effect,)-369.6(a)6.9(nd)]TJ
13.9357 0 TD
[(p)5.1(e).3(rhap)5.1(s)-367.9(a).7(lv)5.8(eolar-re)6.6(generating)]TJ
-13.9357 -1.2203 TD
0 Tc
[(ability,)-281.6(of)-287.8(ovarian)-282(hormone)8.5(s.)-288.8(The)-284.5(loss)-287.1(of)-287.8(alveoli)-279.1(in)-285.1(mice)-284.8(after)]TJ
T*
[(ovariectomy)-669.3(and)-669.8(their)-678.2(regeneratio)10.1(n)-679.9(during)-667.7(estradiol)-672.3(re-)]TJ
0 -1.2266 TD
[(placement)-422.2(suggest)-424.2(estrogen)-423.8(to)-426.9(be)-421.6(the)-427.4(ovarian)-421.1(hormone)-427.8(re-)]TJ
0 -1.2203 TD
[(sponsible)-261.8(for)-256.9(maintaining)-256.2(alveolar)-256.8(structural)-261.6(stability)-255.1(and)-258.8(for)]TJ
T*
[(inducing)-331.7(alveolar)-326.3(regeneratio)10.1(n)-332.2(i)0(n)-335.7(women.)]TJ
6.7246 0 0 5.9768 229.0393 433.8707 Tm
(24,25)Tj
8.9663 0 0 8.9663 72 418.9038 Tm
[(It)-331.4(is)-327.3(important)-332.2(that)-332.6(we)-330.3(analyzed)-328.9(postmenopausal)-332.3(women)]TJ
-1.1128 -1.2203 TD
[(because)-283.9(postmenopause)-284.9(is)-276.7(a)-277.7(factor)-281.4(involved)-283.2(in)-278.8(weakening)-279.3(of)]TJ
T*
[(the)-307.3(lung)-309.9(mechanical)-306.1(function.)-314.8(Because)-307.8(estrogen)-310(deciency)-306.6(is)]TJ
0 -1.2266 TD
[(a)-378.9(known)-382.3(risk)-376.7(factor)-382.6(for)-377(the)-383.1(processes)-380.9(of)-382.6(aging)-375.7(of)-382.6(many)-377.9(tis-)]TJ
0 -1.2203 TD
[(sues,)-291.3(organs,)-293.2(and)-290.4(systems)-297.1(in)-291.5(the)-288.3(human)-296.1(body,)-289.4(ERT)-288.4(has)-295.1(been)]TJ
T*
[(traditionally)-382.5(used)-384.9(to)-376.3(improve)-385.9(structural)-381.8(integrity)-387.6(of)-376.3(the)-383.1(tis-)]TJ
T*
[(sues.)-297.7(Estrogen)-294.2(receptors)-297.2(\(ER\))-299(were)-293(identied)-297.9(in)-297.8(the)-294.6(nuclei)-295.5(of)]TJ
0 -1.2266 TD
[(connective)-297.2(tissue)-292.4(and)-290.4(of)-287.8(the)-294.6(smooth)-286.5(muscle)-293.8(cells)-292.1(of)-287.8(the)-294.6(lung.)]TJ
0 -1.2203 TD
[(These)-544.9(receptors)-543.8(participate)-540.7(in)-538(maintaining)-547(the)-541.2(connective)]TJ
T*
[(tissue)-437.8(by)-432.5(increasing)-430(the)-433.7(synthesis)-436.3(or)-433.4(decreasing)-438.6(the)-433.7(break-)]TJ
0 -1.2266 TD
[(down)-415.5(of)-407.9(collagen.)-417.6(These)-412.2(ndings)-414.1(suggest)-411.5(that)-414.8(estrogen)-411.2(re-)]TJ
0 -1.2203 TD
[(stores)-291(the)-294.6(collagen)-294.5(metabolism)-288.8(and)-290.4(increases)-293.4(the)-294.6(turnover)-294.6(of)]TJ
T*
[(connective)-341.4(tissues)-344.3(of)-338.4(the)-338.9(lung.)]TJ
6.7246 0 0 5.9768 182.2677 291.4015 Tm
[(5,7,11,22)-10.1(,27)]TJ
8.9663 0 0 8.9663 218.948 287.433 Tm
[(Animal)-344(studies)-339.7(have)]TJ
-17.5018 -1.2266 TD
[(shown)-271.7(that)-263.1(ERs)-267.8(regulate)-269(estrogen)-272.1(action)-268.2(on)-265.4(the)-269.3(lung)-265.6(tissue.)]TJ
6.7246 0 0 5.9768 294.4062 280.4597 Tm
(11)Tj
8.9663 0 0 8.9663 72 265.4929 Tm
[(To)-347.2(our)-352.6(knowledge,)-354.7(our)-352.6(article)-348.4(is)-352.6(the)-351.5(rst)-353.2(report)-353.7(with)-350.5(sig-)]TJ
-1.1128 -1.2203 TD
[(nicantly)-463.1(higher)-470.6(values)-461.6(of)-464.8(spirometry)-461.7(parameters)-468.8(in)-462.2(post-)]TJ
T*
[(menopausal)-516(women)-517.4(with)-508.5(POP)-517.9(after)-513.2(6)-511.7(months)-514.7(of)-515.4(ERT.)-512.7(It)]TJ
0 -1.2266 TD
[(should)-458(be)-453.2(noted)-458.5(that)-459.1(our)-453.8(study)-453.2(population)-462.7(was)-451.4(a)-454.8(specic)]TJ
0 -1.2203 TD
[(one.)-369.4(The)-366.7(main)-364.4(strength)-368.1(of)-370(the)-364.2(present)-367.4(study)-371(is)-365.3(sample)-369.9(size,)]TJ
T*
[(strict)-328.2(inclusion)-331.9(criteria,)-326.7(and)-328.4(the)-326.2(fact)-328.5(that)-326.3(study)-333(women)-327.7(were)]TJ
0 -1.2267 TD
[(matched)-249.7(for)-256.9(age,)-247(height,)-252(BMI,)-253.4(parity,)-246.9(and)-252.5(menopausal)-250.5(status.)]TJ
0 -1.2203 TD
[(This)-327.4(reduced)-329.6(the)-326.2(potential)-324.8(errors)-328.6(due)-326.7(to)-325.7(the)-326.2(inuence)-329.9(of)-325.7(sex)]TJ
T*
[(hormones.)-274(Our)-270.7(results)-274.1(are)-265.7(different)-277.4(from)-267.1(the)-275.6(results)-267.8(reported)]TJ
0 -1.2266 TD
[(by)-483.1(other)-487.8(authors)-483.7(because)-486.2(our)-485.4(methodology)-486.6(was)-483(different.)]TJ
0 -1.2203 TD
[(The)-297.1(leading)-289.2(reason)-298.4(is)-289.4(that)-294.7(our)-295.7(subjects)-297.5(were)-293(a)-290.4(representative)]TJ
T*
[(group)-339.4(of)-344.7(women)-340.4(with)-337.8(very)-340.9(poor)-342.7(muscle)-338.1(and)-341(connective)-341.4(tis-)]TJ
0 -1.2266 TD
[(sue.)-309(Furthermore,)-312(our)-314.6(pattern)-309.3(was)-306(large)-311.6(enough,)-309(all)-310.1(subjects)]TJ
0 -1.2203 TD
[(were)-754.6(surgically)-755.1(castrated)-750.3(postmenopausal)-755.9(women)-757.7(with)]TJ
T*
[(previous)-517.5(hysterectomy)-520.4(and)-511.7(oophorectomy,)-520.6(and)-511.7(the)-515.9(study)]TJ
T*
[(group)-440.6(women)-441.5(were)-438.4(taking)-439.4(unopposed)-447.2(estrogen.)-439.4(The)-442.6(most)]TJ
0 -1.2266 TD
[(important)-351.2(evidence)-351.1(for)-351.7(a)-347.3(favorable)-353(effect)-348.2(of)-351(estrogen)-354.3(on)-347.6(the)]TJ
0 -1.2203 TD
[(lung)-442.7(is)-447.4(that)-446.4(the)-446.4(postmenopausal)-446.1(women)-447.9(with)-445.3(genital)-444.7(pro-)]TJ
T*
[(lapse)-543.1(showed)-549.5(improved)-540.7(spirometry)-550.2(parameters)-544.7(following)]TJ
0 -1.2267 TD
[(estrogen)-335.3(therapy)-338.5(administration.)]TJ
29.1107 74.5598 TD
[(The)-366.7(results)-369(of)-370(our)-365.2(study)-364.6(may)-368.2(be)-364.7(explained)-370.4(by)-362.9(a)-366.2(few)-368.7(rea-)]TJ
-1.1128 -1.2203 TD
[(sons;)-270.9(however,)-271.2(we)-267.1(adjusted)-266.4(for)-269.5(many)-264.1(factors)-270.1(that)-269.4(could)-262.9(have)]TJ
0 -1.2266 TD
[(inuenced)-516.3(our)-517(results.)-511(The)-512.1(results)-514.4(remain)-516.8(signicant)-515(and)]TJ
0 -1.2203 TD
[(clinically)-440.9(detectable)-446.7(and)-435.9(are)-442.7(supported)-442.2(by)]TJ
/F6 1 Tf
19.62 0 TD
[(in)-436.3(vitro)]TJ
/F5 1 Tf
3.6104 0 TD
(models.)Tj
-23.2304 -1.2203 TD
[(Estrogen)-287.8(and)-277.8(progestin)-289.7(have)-281.7(been)-279.5(associated)-288.8(with)-280.9(relaxation)]TJ
0 -1.2266 TD
[(of)-287.8(bronchial)-292.4(and)-284.1(airway)-287.5(smooth)-286.5(muscle.)-290.4(Animal)-287.1(and)-290.4(human)]TJ
0 -1.2203 TD
[(models)-286.3(have)-281.7(shown)-278.1(that)-282(both)-282.9(progestin)-283.4(and)-277.8(estrogen)-284.8(induce)]TJ
T*
[(relaxation)-287.4(of)-287.8(bronchial)-279.8(muscle.)-284.1(An)-289.3(alternative)-283.5(explanation)-285.1(of)]TJ
0 -1.2266 TD
[(the)-459(positive)-456.2(association)-453.7(could)-458.9(be)-453.2(that)-452.8(ERT)-452.8(improves)-456.8(mus-)]TJ
0 -1.2203 TD
[(cular)-428(integrity,)-428.4(thus)-430.2(improving)-422.7(pulmonary)-431.9(function.)-428.6(Estro-)]TJ
T*
[(gen)-336.5(and)-334.7(progestin)-340.3(have)-338.7(been)-330.1(found)-339.8(to)-332(increase)-342.6(both)-333.5(muscle)]TJ
T*
[(strength)-709.6(and)-701.4(function)-703.9(and)-701.4(to)-698.8(induce)-706(skeletal)-701.8(myoblast)]TJ
0 -1.2266 TD
[(growth.)-458.9(However,)-457.5(if)-452.9(ERT)-459.2(improves)-456.8(musculoskeletal)-456(integ-)]TJ
0 -1.2203 TD
[(rity,)-524.2(which)-517.1(increases)-527.3(total)-518.9(lung)-518.5(capacity,)-522.4(then)-519.3(spirometry)]TJ
T*
[(tests)-635.8(should)-635(have)-635.8(been)-633.6(signicantly)-636.8(higher)-635(among)-633.6(ERT)]TJ
0 -1.2266 TD
(users.)Tj
6.7246 0 0 5.9768 335.792 565.3983 Tm
(24,25,28,29)Tj
8.9663 0 0 8.9663 370.5448 561.3731 Tm
[(Recently,)-315.2(it)-313.8(has)-314(been)-311.1(discovered)-311.3(that)-313.7(estrogen)]TJ
-6.4114 -1.2203 TD
[(could)-376.7(play)-375.5(a)-372.6(crucial)-373.9(role)-373.6(in)-373.6(collagen)-376.7(production,)-375.6(and)-372.6(it)-377.1(is)-371.6(a)]TJ
T*
[(possible)-277.4(explanation)-272.4(of)-268.8(our)-270.4(results.)]TJ
6.7246 0 0 5.9768 450.1983 543.4581 Tm
(27,32)Tj
8.9663 0 0 8.9663 467.7164 539.4896 Tm
[(A)-273.3(major)-271.1(handicap)-265.9(for)]TJ
-17.2489 -1.2266 TD
[(our)-384.2(research)-384.1(is)-384.2(the)-376.8(very)-385.1(small)-378.5(number)-386.7(of)-376.3(articles)-387.6(regarding)]TJ
0 -1.2203 TD
[(the)-338.9(effects)-336.9(of)-332(estrogen)-341.7(in)-335.7(the)-332.5(human)-334(lung.)]TJ
1.1128 -1.2203 TD
-.0188 Tc
[(Finally,)-268.3(this)-266.7(study)-269.8(i)3(ndicated)-268.4(a)-271.2(b)2.1(enec)-5.4(i)3(al)-268.9(effe)-6.1(ct)-265.9(of)-272.2(estrogen)-268.8(on)]TJ
-1.1128 -1.2203 TD
-.0183 Tc
[(bronchial)-458.1(o)-2.1(r)-455.3(l)3.5(ung)-452.7(t).2(issue.)-457.5(A)5.6(l)-2.9(so,)-457.5(t).2(hese)-454.5(data)-454.1(conrm)-458.5(that)-455.1(HRT)]TJ
0 -1.2266 TD
[(shou)5.7(ld)-470.1(be)-473.3(recommended)-470.1(to)-476.2(all)-477(p)-.6(ostmenopausal)-470.7(w)-.9(omen,)-476.4(e).9(s-)]TJ
0 -1.2203 TD
-.0185 Tc
[(pec)-5.1(i)3.3(ally)-332.7(to)-331.1(thos)5.5(e)-334.5(w)-1.2(ith)-338(p)-.9(elvic)-327.6(o)-2.3(rg)]TJ
13.8282 0 TD
[(an)-331.7(prolapse.)-331.2(O)-2.6(ur)-329(ndings)-336(c)1.2(all)]TJ
-13.8282 -1.2203 TD
-.0188 Tc
[(f)-6.6(o)3.7(r)-468.4(a).7(dditional)-464.9(s)-1.1(tudies)-469(of)-468.2(the)-461.3(p)-1.2(otential)-464.9(effe)-6.1(cts)-462.7(o)-2.6(f)-468.2(e).3(strogen)-464.8(r)-.5(e-)]TJ
0 -1.2266 TD
-.0184 Tc
[(placement)-341.3(a)1.1(dministration)-337.9(o)-2.2(n)]TJ
12.6395 0 TD
-.0175 Tc
[(pul)4.3(m)3.9(o)-1.3(nary)-338.1(fu)6.4(nctio)5(n)-343.4(i)4.3(n)-337(postm)3.9(e)1.6(n-)]TJ
-12.6395 -1.2203 TD
-.0172 Tc
[(opausal)-248.4(w).1(om)4.2(en,)-247.7(e)1.9(speci)4.6(a)2.3(ll)4.6(y)-249.2(t)1.3(o)-253.9(t)1.3(ho)5.3(se)-251(wi)4.6(th)-254.5(pelv)7.4(ic)-250.4(org)3.7(a)2.3(n)-254.5(p)6.7(rolap)6.7(s).5(e.)]TJ
/F3 1 Tf
0 -2.6683 TD
0 Tc
(Acknowledgments)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(This)-504.4(study)-510.1(was)-502(supported)-511.7(by)-502(the)-503.3(Croatian)-509.6(Ministry)-503(of)]TJ
-1.1128 -1.2203 TD
[(Science,)-632.6(Education)-629.6(and)-625.5(Sports)-631.1(project)-629.1(\(No.)-625.8(216-0000000-)]TJ
T*
[(0535\);)-640.1(head)-638.1(researcher)-637.6(Professor)-643.6(Tomislav)-637.9(Strinic,)-638.3(M.D.,)]TJ
0 -1.2267 TD
(Ph.D.)Tj
/F3 1 Tf
0 -2.6619 TD
[(Author)-338.7(Disclosure)-336.7(Statement)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(We)-397.3(certify)-400.8(that)-402.2(all)-392.3(of)-401.6(the)-395.8(authors)-401.5(did)-395.2(not)-398.7(have)-401.9(any)-393(rela-)]TJ
-1.1128 -1.2266 TD
[(tionship)-260(with)-261.9(companies)-255.2(that)-256.8(may)-254.4(have)-262.8(a)-252.4(nancial)-255.4(interest)-262.6(in)]TJ
0 -1.2203 TD
[(the)-338.9(information)-340.6(contained)-331.4(in)-335.7(the)-338.9(manuscript.)]TJ
/F3 1 Tf
0 -2.5228 TD
(References)Tj
/F5 1 Tf
8.4682 0 0 8.4682 317.3102 266.6833 Tm
[(1.)-501.9(Nelson)-334.4(HD.)-340.5(Menopause.)-339.2(Lancet)-337.3(2008;371:760770.)]TJ
0 -1.2385 TD
[(2.)-501.9(Lund)-458.9(K.)-458(Menopause)-462(and)-459.6(the)-459(menopausal)-465.4(transition.)-465.3(Med)]TJ
1.2519 -1.2318 TD
[(Clin)-333.8(N)-336.2(A)0(m)-336.7(2008;92:12531271.)]TJ
-1.2519 -1.2385 TD
[(3.)-501.9(Stevenson)-265.5(JC.)-266.5(A)-261(womans)-264.3(journey)-261.8(through)-265.7(the)-264.8(reproductive,)]TJ
1.2519 -1.2318 TD
[(transitional)-389.5(and)-379.3(postmenopausal)-394.3(periods)-380.8(of)-382.2(life:)-386.4(Impact)-381.1(on)]TJ
0 -1.2385 TD
[(cardiovascular)-547.3(and)-546.7(musculo-skeletal)-553.9(risk)-541.8(and)-546.7(the)-546(role)-547.7(of)]TJ
0 -1.2318 TD
[(estrogen)-339.8(replacement.)-339.4(Maturitas)-336.6(2011;70:197205.)]TJ
-1.2519 -1.2385 TD
[(4.)-501.9(AACE)-408.4(Menopause)-415.1(Guidelines)-417.6(Revision)-410.7(Task)-411.8(Force)-408.7(Ameri-)]TJ
1.2519 -1.2318 TD
[(can)-412.4(Association)-419.4(of)-409(ClinicalEndocrinologists)-426.4(medical)-410.2(guide-)]TJ
0 -1.2385 TD
[(lines)-352(for)-352.1(clinical)-351.1(practice)-359.6(for)-352.1(the)-351.9(diagnosis)-349.3(and)-352.5(treatment)-358.6(of)]TJ
0 -1.2318 TD
[(menopause.)-341(Endocr)-331.6(Pract)-340.5(2006;12:315317.)]TJ
-1.2519 -1.2385 TD
[(5.)-501.9(Carey)-406.4(MA,)-406.3(Card)-407.3(JW,)-409.7(Voltz)-403(JW,)-409.7(Germolec)-411.1(DR,)-402.8(Korach)-408.6(KS,)]TJ
1.2519 -1.2318 TD
[(Zeldin)-441.9(DC.)-441.1(The)-444.8(impact)-439.8(of)-442.5(sex)-440.4(and)-439.6(sex)-447.1(hormones)-443.6(on)-440.2(lung)]TJ
0 -1.2385 TD
[(physiology)-334.3(and)-325.7(disease:)-332.7(Lessons)-329.5(from)-334(animal)-325(studies.)-332.2(Am)-330(J)]TJ
0 -1.2318 TD
[(Physiol)-339(Lung)-336.8(Cell)-330.7(Mol)-336.5(Physiol)-339(2007;293:272278.)]TJ
-1.2519 -1.2385 TD
[(6.)-501.9(Sharma)-290(G,)-288.8(Goodwin)-300(J.)-284.9(Effect)-296.7(of)-288.5(aging)-294.6(on)-292.9(respiratory)-293.5(system)]TJ
1.2519 -1.2318 TD
[(physiology)-260.6(and)-252.1(immunolog)-10.5(y.)-249.1(Clin)-260.2(Interv)-256.9(Aging)-258.9(2006;1:)-253.7(253)]TJ
0 -1.2385 TD
(260.)Tj
-1.2519 -1.2318 TD
[(7.)-501.9(Massaro)-455.8(D,)-459.6(DeCarlo)-457.6(Massaro)-462.5(G.)-456.2(Toward)-456.2(therapeutic)-461.7(pul-)]TJ
1.2519 -1.2385 TD
[(monary)-391(alveolar)-391.8(regeneration)-404.2(in)-385.5(humans.)-399.6(Proc)-387.2(Am)-396.9(Thorac)]TJ
T*
[(Soc)-336.4(2006;3:709712.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(4)Tj
47.8771 0 TD
[(STIPIC)-333.8(ET)-338.7(AL.)]TJ
ET
endstream
endobj
59 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 62 0 R/MediaBox[0 0 612 792]/Annots[63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R]/Rotate 0>>
endobj
90 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
60 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.4682 0 0 8.4682 64.0063 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(8.)-501.9(Miller)-466.7(MR,)-463.4(Crapo)-466.4(R,)-469.8(Hankinson)-467.6(J,)-465.7(Brusasco)-466.3(V,)-464.7(Burg)-8.3(os)-462.3(F,)]TJ
1.2519 -1.2318 TD
[(Casaburi)-510.4(R,)-510(Coates)-506.2(A,)-513.1(Enright)-508(P,)-509.3(van)-508.3(der)-511.3(Grinten)-509.6(CPM,)]TJ
0 -1.2385 TD
[(Gustafsson)-243.4(P,)-234.9(Jensen)-241.5(R,)-235.5(Johnson)-239.9(DC,)-233.6(MacIntyre)-240.6(N,)-240.2(McKay)-236.9(R,)]TJ
0 -1.2318 TD
[(Navajas)-407.5(D,)-406(Pedersen)-417.8(OF,)-405.4(Pellegrino)-411.7(R,)-409.6(Viegi)-404.7(G,)-409.3(Wanger)-406(J.)]TJ
0 -1.2385 TD
[(General)-241.5(considerations)-245(for)-238.2(lung)-238.1(function)-243(testing.)-244.7(Eur)-239(Respir)-243.8(J)]TJ
0 -1.2318 TD
(2005;26:153161.)Tj
-1.2519 -1.2385 TD
[(9.)-501.9(Miller)-332.8(MR,)-329.5(Hankinson)-340.4(J,)-325.1(Brusasco)-339.1(V,)-330.8(Burgos)-330.1(F,)-329.4(Casaburi)-336.3(R,)]TJ
1.2519 -1.2318 TD
[(Coates)-372.3(A,)-365.8(Crapo)-372.7(R,)-369.4(Enright)-367.4(P,)-368.8(van)-374.4(der)-370.7(Grinten)-369(CPM,)-370.7(Gus-)]TJ
0 -1.2385 TD
[(tafsson)-439.2(P,)-429(Jensen)-435.7(R,)-436.4(Johnson)-434(DC,)-434.4(MacIntyre)-441.5(N,)-427.6(McKay)-437.7(R,)]TJ
0 -1.2318 TD
[(Navajas)-407.5(D,)-406(Pedersen)-417.8(OF,)-405.4(Pellegrino)-411.7(R,)-409.6(Viegi)-404.7(G,)-409.3(Wanger)-406(J.)]TJ
0 -1.2385 TD
[(Standardisation)-243.5(of)-234.9(spirometry.)-241(Eur)-239(Respir)-237.1(J)-240.4(2005;)-233.8(26:319338.)]TJ
-1.754 -1.2318 TD
[(10.)-504(Steenbruggen)-255.7(I,)-247.2(Mitchell)-250.4(S,)-254.3(Severin)-252.1(T,)-243.9(Palange)-256.3(P,)-248.3(Cooper)-252(BG.)]TJ
1.754 -1.2385 TD
[(Harmonising)-275.2(spirometry)-283.5(education)-274.6(with)-281.6(HERMES:)-276.7(Training)]TJ
0 -1.2318 TD
[(a)-236.4(new)-235.9(generation)-246.3(of)-241.6(qualied)-234.3(spirometry)-243.3(practitioners)-247.8(across)]TJ
0 -1.2385 TD
[(Europe.)-335.2(Eur)-332.7(Respir)-337.6(J)-334.1(2011;37:47948)-7.4(1.)]TJ
-1.754 -1.2318 TD
[(11.)-504(Lieberman)-510.3(D,)-506.4(Kopernic)-517.3(G,)-503(Porath)-514.7(A,)-506.4(Levitas)-509.1(E,)-511.7(Lazer)-508.8(S,)]TJ
1.754 -1.2385 TD
[(Heimer)-523.7(D.)-513.1(Inuence)-525.6(of)-522.8(estrogen)-520.5(replacement)-529.1(therapy)-517.8(on)]TJ
0 -1.2318 TD
[(airway)-336.6(reactivity.)-333.1(Respiration)-344.2(1995;62:205208.)]TJ
-1.754 -1.2385 TD
[(12.)-504(Balzano)-304.7(G,)-295.5(Fuschillo)-310.6(S,)-301.2(Melillo)-297.5(G,)-302.2(Bonini)-309(S.)-301.2(Asthma)-300.8(and)-299(sex)]TJ
1.754 -1.2385 TD
[(hormones.)-340.9(Allergy)-332.9(2001;56:1320.)]TJ
-1.754 -1.2318 TD
[(13.)-504(Carlson)-352.8(CL,)-359.4(Cushman)-356.6(M,)-352.8(Enright)-354(PL,)-353.9(Cauley)-359.2(JA,)-351.8(Newman)]TJ
1.754 -1.2385 TD
[(AB.)-263.9(Hormone)-268.1(replacement)-268(therapy)-270.1(is)-267.1(associated)-268.3(with)-268.2(higher)]TJ
0 -1.2318 TD
[(FEV1)-384.3(in)-392.2(elderly)-388.7(women.)-390.9(Am)-383.5(J)-387.6(Respir)-391.1(Crit)-392.8(Care)-389.3(Med)-387.7(2001;)]TJ
0 -1.2385 TD
(163:423428.)Tj
-1.754 -1.2318 TD
[(14.)-504(Pata)-321.1(O,)-328(Atis)-326.6(S,)-321.3(Utku)-327.1(Oz)-325.8(A,)-319(Yazici)-327.6(G,)-322.3(Tok)-324.8(E,)-324.3(Pata)-327.8(F,)-322.7(Kilic)-325.1(C,)]TJ
1.754 -1.2385 TD
[(Camdeviren)-394.8(H,)-394.2(Albam)-389.5(M.)-393(The)-391.2(effects)-398.3(of)-388.9(hormone)-397.6(replace-)]TJ
0 -1.2318 TD
[(ment)-474.4(therapy)-484.3(type)-475.1(on)-480.4(pulmonary)-477.2(functions)-483.1(in)-472.6(postmeno-)]TJ
0 -1.2385 TD
[(pausal)-337.2(women.)-337.3(Maturitas)-336.6(2003;46:213218.)]TJ
-1.754 -1.2318 TD
[(15.)-504(Cevrioglu)-509.5(AS,)-508.6(Fidan)-510.4(F,)-510.2(Unlu)-508.8(M,)-506.8(Yilmazer)-509.4(M,)-506.8(Orman)-508.9(A,)]TJ
1.754 -1.2385 TD
[(Fenkci)-438.5(IV,)-439.6(Serteser)-451(M.)-433.1(The)-444.8(effects)-445.1(of)-442.5(hormone)-437.8(therapy)-444.1(on)]TJ
0 -1.2318 TD
[(pulmonary)-437.1(function)-443.8(tests)-439.4(in)-439.1(postmenopausal)-447.9(women.)-437.7(Ma-)]TJ
0 -1.2385 TD
[(turitas)-334.3(2004;49:221227.)]TJ
-1.754 -1.2318 TD
[(16.)-504(Roberts)-452.7(H.)-454.4(Managing)-454.7(the)-459(menopause.)-454.8(Br)-457.1(Med)-454.7(J)-447.9(2007;334:)]TJ
1.754 -1.2385 TD
(736741.)Tj
-1.754 -1.2318 TD
[(17.)-504(Gompel)-391.8(A,)-385.9(Rozenberg)-390.8(S,)-388.2(Barlow)-390.9(DH.)-387.4(The)-391.2(EMAS)-389.2(2008)-383.4(up-)]TJ
1.754 -1.2385 TD
[(date)-395.6(on)-400(clinical)-397.9(recommendations)-404.4(on)-400(postmenopausal)-407.7(hor-)]TJ
0 -1.2318 TD
[(mone)-335.7(replacement)-341.7(therapy.)-334.7(Maturitas)-336.6(2008;61:22732.)]TJ
-1.754 -1.2385 TD
[(18.)-504(Hansen)-358.9(LB,)-356.3(Portman)-356.1(D.)-359.1(Hormone)-355.2(therapy)-357.1(update.)-358.8(Current)]TJ
1.754 -1.2318 TD
[(recommendations)-745.8(formenopausal)-750.5(symptoms.)-743.5(US)-745.2(Pharm)]TJ
0 -1.2385 TD
(2006;31:8689.)Tj
-1.754 -1.2318 TD
[(19.)-504(Seaton)-518.1(A.)-513.1(Pulmonary)-517.4(capillary)-514.8(blood)-513.7(volume)-516.1(in)-512.7(women:)]TJ
1.754 -1.2385 TD
[(Normal)-572.7(values)-567.6(and)-573.5(effect)-573.2(of)-569.7(oral)-569.2(contraceptives.)-582.7(Thorax)]TJ
0 -1.2318 TD
(1972;27:7579.)Tj
-1.754 -1.2385 TD
[(20.)-504(Saaresranta)-622.6(T,)-612.2(Polo)-621.5(O.)-615.9(Hormones)-622(and)-620.3(breathing.)-620.7(Chest)]TJ
1.754 -1.2318 TD
(2002;122;21652182.)Tj
-1.754 -1.2385 TD
[(21.)-504(Strinic)-609.7(T,)-605.5(Eterovic)-604.3(D.)-606.8(Oral)-603.7(contraceptives)-618.4(improve)-606.5(lung)]TJ
1.754 -1.2318 TD
[(mechanics.)-340.3(Fertil)-335.4(Steril)-333.9(2003;79:10701073.)]TJ
-1.754 -1.2385 TD
[(22.)-504(Bump)-334.3(RC,)-337.6(Mattiasson)-341.3(A,)-339(Bo)-334.5(K,)-337.5(Brubaker)-339.4(LP,)-340.5(DeLancey)-342.2(JO,)]TJ
1.754 -1.2318 TD
[(Klarskov)-537.2(P,)-542.8(Shull)-538(BL,)-537.1(Smith)-536.4(AR.)-543.4(The)-538.5(standardization)-544.6(of)]TJ
0 -1.2385 TD
[(terminology)-253.6(of)-248.3(female)-252.6(pelvic)-256.8(organ)-248.4(prolapse)-253.3(and)-252.1(pelvic)-250.1(oor)]TJ
0 -1.2318 TD
[(dysfunction.)-342.4(Am)-330(J)-334.1(Obstet)-339.1(Gynecol)-338.9(1996;175:1017.)]TJ
27.8972 61.7594 TD
[(23.)-497.3(McCormack)-311.9(MC,)-314.3(Shade)-315.2(D,)-305.6(Wise)-312.1(RA.)-315.8(Spirometer)-317(calibration)]TJ
1.7473 -1.2318 TD
[(checks:)-335.9(Is)-335.6(3.5%)-333.8(good)-339.5(enough?)-335.4(Chest)-339.2(2007;131:14861493.)]TJ
-1.7473 -1.2385 TD
[(24.)-497.3(Massaro)-342(D,)-332.4(DeCarlo)-337.1(Massaro)-335.3(G.)-335.7(Estrogen)-337.7(regulates)-339.9(pulmo-)]TJ
1.7473 -1.2318 TD
[(nary)-240.5(alveolar)-237.8(formation,)-238(loss,)-238.3(and)-238.7(regeneration)-243.5(in)-231.6(mice.)-239.7(Am)-236.2(J)]TJ
0 -1.2385 TD
[(Physiol)-339(Lung)-336.8(Cell)-330.7(Mol)-336.5(Physiol)-339(2004;287:11541159.)]TJ
-1.7473 -1.2318 TD
[(25.)-497.3(Massaro)-308.5(D,)-305.6(Biadasz)-303.9(Clerch)-302.3(L,)-304.2(DeCarlo)-303.6(Massaro)-308.5(G.)-302.2(Estrogen)]TJ
1.7473 -1.2385 TD
(receptor-)Tj
/F11 1 Tf
3.9298 0 TD
(a)Tj
/F5 1 Tf
.8636 0 TD
[(regulates)-373.3(pulmonary)-370.1(alveolar)-365(loss)-367.8(and)-365.9(regenera-)]TJ
-4.7935 -1.2318 TD
[(tion)-566.9(in)-566.3(female)-567.3(mice:)-561.1(Morphometric)-572(and)-560.1(gene)-571.1(expression)]TJ
0 -1.2385 TD
[(studies.)-613.3(Am)-611.1(J)-601.9(Physiol)-613.5(Lung)-611.3(Cell)-605.2(Mol)-611(Physiol)-613.5(2007;293:)]TJ
0 -1.2318 TD
(222228.)Tj
-1.7473 -1.2385 TD
[(26.)-497.3(Strinic)-428.9(T,)-418(Eterovic)-430.3(D,)-419.4(Dujic)-421.5(Z,)-423(Markovic)-424.4(V,)-424.5(Tocilj)-425.4(J.)-418.8(Spiro-)]TJ
1.7473 -1.2318 TD
[(metric)-545.9(disorders)-546.2(in)-546.2(women)-540.4(with)-549.4(genital)-545.5(descensus.)-548.5(Acta)]TJ
0 -1.2385 TD
[(Obstet)-339.1(Gynecol)-338.9(Scand)-332.8(1997;76:879883.)]TJ
-1.7473 -1.2318 TD
[(27.)-497.3(Lieberman)-463.4(D,)-459.6(Kope)-9.8(rnik)-459.4(G,)-456.2(Porath)-467.9(A,)-459.6(Lazer)-461.9(S,)-461.8(Heimer)-463.5(D.)]TJ
1.7473 -1.2385 TD
[(Sub-clinical)-325.6(worsening)-320.8(of)-315.3(bronchial)-324.4(asthma)-316.4(during)-320.2(estrogen)]TJ
0 -1.2318 TD
[(replacement)-381.9(therapy)-377.2(in)-372.1(asthmatic)-381(postmenopausal)-380.9(women.)]TJ
0 -1.2385 TD
[(Maturitas)-336.6(1995;21:15315)-7.4(7.)]TJ
-1.7473 -1.2318 TD
[(28.)-497.3(Heikkinen)-386.2(J,)-385.4(Kyllonen)-386.7(E,)-377.8(Kurttila-Matero)-386.9(E,)-384.5(Wilen-Rosenq-)]TJ
1.7473 -1.2385 TD
[(vist)-420.7(G,)-416(Lankinen)-418.1(KS,)-420(Rita)-420.2(H,)-414.2(Vaananen)-418.3(HK.)-419.3(HRT)-418.6(and)-419.5(ex-)]TJ
T*
[(ercise:)-475(Effects)-476.5(on)-467(bone)-471.3(density,)-471.6(musc)-8.8(le)-469.5(strength)-474.8(and)-466.3(lipid)]TJ
0 -1.2318 TD
[(metabolism.)-269.3(A)-267.7(placebo)-263.3(controlled)-274.5(2-year)-265.6(prospective)-269.8(trial)-266.2(on)]TJ
0 -1.2385 TD
[(two)-252.2(estrogen-progestin)-259.5(regimens)-247.6(in)-244.9(healthy)-254.5(postmenopausal)]TJ
0 -1.2318 TD
[(women.)-337.3(Maturitas)-336.6(1997;26:139149.)]TJ
-1.7473 -1.2385 TD
[(29.)-497.3(Lowe)-325.7(DA,)-318.9(Baltgalvis)-327.1(KA,)-324(Greising)-322(SM.)-321.5(Mechanisms)-323.7(behind)]TJ
1.7473 -1.2318 TD
[(estrogens)-483.9(benecial)-476.5(effect)-479.5(on)-473.7(muscle)-478.3(strength)-481.5(in)-472.6(females.)]TJ
0 -1.2385 TD
[(Exerc)-334.2(Spor)-9.6(t)-334.1(Sci)-335.3(Rev.)-330.2(2010;38:)-336.1(6167.)]TJ
-1.7473 -1.2318 TD
[(30.)-497.3(Sarwar)-465.4(R,)-456.4(Beltran)-469.8(N,)-454.4(Rutherford)-471.1(OM.)-462.2(Changes)-463.2(in)-459.2(muscle)]TJ
1.7473 -1.2385 TD
[(strength,)-392.2(relaxation)-386.6(rate)-387(and)-379.3(fatigability)-388.9(during)-387.2(the)-385.3(human)]TJ
0 -1.2318 TD
[(menstrual)-341.3(cycle.)-333.3(J)-334.1(Physiol)-339(1996;493:267272.)]TJ
-1.7473 -1.2385 TD
[(31.)-497.3(Kahlert)-349.1(S,)-341.3(Grohe)-346.9(C,)-347.5(Karas)-339.7(RH,)-350.8(Lobbert)-345.2(K,)-344.2(Neyses)-346(L,)-344.4(Vetter)]TJ
1.7473 -1.2318 TD
[(H.)-280.4(Effects)-282.3(of)-281.8(estrogen)-286.2(on)-279.5(skeletal)-287(myoblast)-279.2(growth.)-280.7(Biochem)]TJ
0 -1.2385 TD
[(Biophys)-337.4(Res)-337.9(Commun)-334.9(1997;232:373378.)]TJ
-1.7473 -1.2318 TD
[(32.)-497.3(Hansen)-506.2(M,)-493.4(Kongsgaard)-504.6(M,)-500.1(Holm)-500.4(L,)-498.3(Skovgaard)-499.3(D,)-499.7(Mag-)]TJ
1.7473 -1.2385 TD
[(nusson)-518.6(SP,)-511.5(Qvortrup)-517.7(K,)-511.6(Larsen)-509.5(JO,)-514.9(Aagaard)-513.8(P,)-509.3(Dahl)-514.8(M,)]TJ
0 -1.2318 TD
[(Serup)-266.2(A,)-258.7(Frystyk)-264.1(J,)-264.9(Flyvbjerg)-265.5(A,)-258.7(Langberg)-267.1(H,)-260.3(Kjaer)-264.1(M.)-259.1(Effect)]TJ
0 -1.2385 TD
[(of)-355.5(estrogen)-353.1(on)-353.2(tendo)-10.3(n)-351.9(collagen)-351.4(synthesis,)-361.1(tendon)-355.4(structural)]TJ
0 -1.2318 TD
[(characteristics,)-433.1(and)-426.2(biomechanical)-431.3(properties)-428.5(in)-425.7(postmeno-)]TJ
0 -1.2385 TD
[(pausal)-337.2(women.)-337.3(J)-334.1(Appl)-333.8(Physiol)-339(2009;106:13851393.)]TJ
8.9663 0 0 8.9663 439.2566 317.7637 Tm
[(Address)-339.4(correspondence)-340.1(to:)]TJ
/F6 1 Tf
5.5768 -1.2203 TD
[(Tomislav)-335.7(Strinic)]TJ
-10.3949 -1.2266 TD
[(Department)-337.8(of)-330(Gynecology)-340.7(and)-332(Obstetrics)]TJ
9.0923 -1.2203 TD
[(University)-333.7(Hospital)]TJ
2.9591 -1.2203 TD
[(Spinciceva)-331.4(1)]TJ
.3604 -1.2266 TD
[(21000)-332.7(Split)]TJ
1.7957 -1.2203 TD
(Croatia)Tj
-8.2704 -2.447 TD
(E-mail:)Tj
/F5 1 Tf
3.2563 0 TD
(tstrinic@kbsplit.hr)Tj
/F6 1 Tf
-1.6756 -1.8336 TD
[(Received:)-337.6(April)-335.6(2,)-331.2(2012)]TJ
-.1265 -1.2203 TD
[(Accepted:)-339.1(July)-335.1(25,)-330.7(2012)]TJ
/F3 1 Tf
-44.899 61.0098 TD
[(ESTROGEN)-339.9(IMPROVES)-337.8(LUNG)-330.5(FUNCTION)]TJ
54.1178 0 TD
(5)Tj
ET
endstream
endobj
91 0 obj
<>stream
JKOPHO+AdvPSMP10 qE
AdvPSMP10 B d]^5ObLQYu yhgbz =3K u}G][1,9ĿGA
endstream
endobj
92 0 obj
<>
endobj
93 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
94 0 obj
[/Indexed/DeviceRGB 255 93 0 R]
endobj
33 0 obj
<>
endobj
61 0 obj
<>
endobj
95 0 obj
<>stream
8;Z\6#nFiq%-.@0b]bCV*!L@AcqUXMF\Epu2A?.9iBZ\t6X12A'T5570AK+=-au_>
=>OfESh"6"isVi._tN=i-QB$I;WkR_M-QUVqKI="eK.p5-(=[?"tHH@Hk?a.\LVX.
mMCfNK^&04q0W`AE%TDG]/+0g&_\e5nmfk&9l6f[OJB/p`S6m#`l2aF?edk9gunI1brnJM=oeST"~>
endstream
endobj
37 0 obj
<>stream
8;Z\78J8o`%.!pXaEMr%;Za8;&uO.Qe;9)7#r'`['9RNn"s$Q8Al63[ZpVb/mIK?C
?B?>.4n96bXC,J!.4hOlN*g'`c3kO+f@X>1HDuTaV1GIf3eP.Qrs9alab^O5uqJR?8;&_2]W%I%T;Q)J+0-2KN>$UUi$K@3n)bDWWoQs?"j
S\08Np!0?Ijr#7AA[ns5.I(Z!=Dd=.6&gb/Ml]SCdMaCJ&hm1T\Yl6&06o+Ecc.7^UdF(O^4r1rtDV/1*,(a%+X)?%e$
Xa[PLW>Fk.,3KEVjVkC/"#5K`02k47ggeNZ)K8DD8&d.!TJ%$V`QGi~>
endstream
endobj
44 0 obj
<>stream
8;Z\7$')nG%.sQakjPS[,dG0%"DFfp<@J'7@:hKWpr5RL*5R]fEgmh9OePh&Y?B8,
12-!2T\Xs24K:OBnVY$e=Hi[RS7J&a`SdRZ"gMZo2do058pE.spnXj>>qD#gJMf5_
?D3IrdPEJ4ngJ8WZGQZRnMmgLquW,7guk"IIV1%b'(/#-N$D%fNS?4hqO0l$h.!@=
Ut=4N1`F!;X._m*n$(WR(&JTW[==;N(?up"#,59A`sRgN#0-jfbj9jeC7BPD%U`H(
%;q"Z/7'1dlT"4%Ts=!oLDSR\92Iau*3f1-HbB(J"dK>c+VVj&ND0X6CoFT0Ha@)%
"S">&D8Dc!>;WeC`$12(a:Tu*fd=HBNP[LYn#M3H8`Of!H2gr6a7+o+`$?[
2p/^*7qh.h]\InLEY=fbku,f("NHOB-$bT8+hpM,;Vgt>H&$Xp)MKhkYbX`008sA"
C7H0n'k;i&'p_Z9`k"/XDFA>D>$U=?L/0k+:A%^)IQ:$HgZ
endstream
endobj
48 0 obj
<>stream
8;Z\7$a.Ai%*ST&R-Qm!NBi#U%tmuI(2;T<_6H_-%.P,q!F(1KA4^p
%?69#j3_GF+N-oKoU]FdA)TR]Sj@a#2`80]FiDPfS:Ph1$"nK?SjEUW>$+FhnQZ\l
]B/(\Fm(_?nuoU,_cSX2=^ggB`&[ub#b;6q\lC^IWc*k>QIn4J!^0%#Y6V=Mpm+1H
S1//Fi-SrJl@1A>/*P#d^PPU=reTj'.%OBtdde9>r$mGLr\bI1670l//Cnn>Z)!5]
7a;4]9G"UgRE6tBe\nJScHRB22@tsDC;7VO_gtN3TRc0l7pm.maJY=M'f!/0pZh*O
,KiiJpU%[!_Nq,.MeT9S=k=/:'OO5,!OR0O3cN^p-XQ?MY\K^-l\J\FlDjU*p/-Pf
'u#Be)f6Z"jCL'D1?UAWcGH;58P='Y[mRgVK*oAAUmI=fjNTL"0>9@D"oqd>[/g~>
endstream
endobj
62 0 obj
<>stream
8;Z\6>B7Y9#ikn#j>uZRd=]AW*j,$F[b]%b[K.PiAkm\]dC,O"a2[gkp7"k=P1B--
Xs>'TG=a3e2$5oE#"J@TQ4[u;,1GO5X3e:pq;8oRIS3
01)eN!)`RU*V&IE\PIA,[=T//Nr;tg&LUF8SQ=gOU`s]'k&GB!E0W4\J)_")!kl\0
nDjT!MA_:jbd#Ktq\#,]*Y"=7I&\OUJclt7e52o/'\l$C0BDd5&X$4G`Qp
nYIoFF/c/b2!!$[A$!1Wj:IJ(&J,0X4"9`#@'O"@4gh^nj:2nhSEtn6A+RpkmqaZa
q=to4kRS9(`1`'(#]i"2;)a8`P-C*FH6#LlYdn>`6,-+0Cq+L$p=jNIpU$k'^FDqH@\:YEKT
bZ,tNO?kkF$KK/>$k]`3[5fd.;i:9E'+)5KarF%P^pk:)P#579b<;P,]iX+)eU+a4m;q$I]/0`#=#@&D$hkI<0u.+TiA'F]r8_3APB&'dVKa3L8E
7EnC0ian+pinAJ(27.Wp-c[%&ItUlq9sCR,]:lW6hkbU'1UXH9]BZo7pV<7/0YM7n
SW@!I[JL%hIW6(t>W&'s&6VWblAqL"S&.8tZn`%`mEQ5i'A'U*e##j/2N@Dd!9c7gf)~>
endstream
endobj
96 0 obj
<>
endobj
97 0 obj
<>
endobj
29 0 obj
<>
endobj
99 0 obj
<>
endobj
98 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 95 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
112 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
108 0 obj
<>
endobj
109 0 obj
<>
endobj
32 0 obj
<>
endobj
110 0 obj
<>
endobj
34 0 obj
<>
endobj
115 0 obj
<>
endobj
117 0 obj
<>
endobj
31 0 obj
<>
endobj
100 0 obj
<>stream
HTn0+t\1-D-j4B{HrPVb%;uKRP#2"wvz}(g%MhR>̨"g:w\S"I(LlgYָ(kx]çatvmt9'94MkчPnC|Uݛ!-Έ`2R-?bnڮrင宫0h&(+;cj7Tې&B|mcDs3nb& kFG˅<N+|0Og Ec,#j}rOxv(Fg9bDȑiE8-N5xԓu<.
")Uoe- 7JtUwߤ{E2B}B]A)EĉSQ@iIa[c+l%k~IGxUŒ.ָ%ԴQR?ިʵ,Wϊsr%;9v]:WhpVxi4#M$c*ɘ/#es0!x}DCf0$7i{_+~8Q0ѐv>k]%; xt'Ax$kzmdtaz+u>]sO\шXMF<|/~V`fr6έF~hu5\5z%p[~c=ܤ!$SW+93+\CiQ\l\0X%Nd}p(`Hz`
endstream
endobj
35 0 obj
<>
endobj
36 0 obj
<>
endobj
120 0 obj
<>
endobj
125 0 obj
<>stream
hbd`ab`ddvL){XHxd1031(00232*}Wcߍ!|KWh]z@bD~!%gQȏElY ?tDA411w#tDYmKWgݡe3ڽg]|҄Dɩ./λj㙻&;su]` EP6}.6 o q9{D "
endstream
endobj
123 0 obj
<>
endobj
122 0 obj
<>stream
hTP=o jtR~v'H${3ƚ O <-^!t8E ڨgWt@]cc 8'#s+p)>b]6 !@cOh"ݫh.C(s^'
/;\JhTշdc2V1.YQ8ct$ůvk+I̪ޙk